var title_f16_32_16896="Giant papillae in giant papillary conjunctivitis";
var content_f16_32_16896=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F74752&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F74752&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Giant papillary conjunctivitis with giant papillae on the palpebral conjunctiva",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 320px; height: 223px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Reaction to lid movement over a foreign substance, such as contact lens.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_32_16896=[""].join("\n");
var outline_f16_32_16896=null;
var title_f16_32_16897="Bronchial atresia CXR";
var content_f16_32_16897=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F82218&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F82218&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Bronchial atresia in infant",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 360px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A chest radiograph shows marked hyperexpansion and oligemia of the left upper lobe. A small suprahilar nodule is visible in the left upper lobe.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_32_16897=[""].join("\n");
var outline_f16_32_16897=null;
var title_f16_32_16898="Fontanelles and suture lines";
var content_f16_32_16898=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F81518&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F81518&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 522px\">",
"   <div class=\"ttl\">",
"    Fetal head at term showing fontanelles, sutures, and biparietal diameter",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 502px; height: 473px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_32_16898=[""].join("\n");
var outline_f16_32_16898=null;
var title_f16_32_16899="ICD PI";
var content_f16_32_16899=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F67053&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F67053&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    ICDs and pacemakers compared",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 445px; height: 297px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    ICDs or \"implantable cardioverter defibrillators\" work differently than pacemakers do. Both devices are implanted under the skin and have wires called \"electrodes\" leading to the heart. Both devices send electrical signals to the heart to keep it beating normally. But ICDs can give a much more powerful jolt to the heart if it starts to beat in a dangerous way. Pacemakers cannot do that.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     file://www.nhlbi.nih.gov/health/dci/Diseases/icd/icd_whatis.html.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_32_16899=[""].join("\n");
var outline_f16_32_16899=null;
var title_f16_32_16900="Vaginal retractors";
var content_f16_32_16900=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F68514&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F68514&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 495px\">",
"   <div class=\"ttl\">",
"    Vaginal retractors",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 475px; height: 317px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Schieden retractor. (B) Auvard weighted speculum.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of William J Mann, Jr, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_32_16900=[""].join("\n");
var outline_f16_32_16900=null;
var title_f16_32_16901="Chagas disease map";
var content_f16_32_16901=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F74490&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F74490&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Emerging Chagas disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 476px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Areas of acute T. cruzi infection in the Amazon Basin. Number of cases per region: French Guiana: 15; Colombia: 100; Ecuador: 14; Peru: 55; Brazilian States: Amapa: 27, Acre: 7, Amazonas: 33, Para: 57, Maranhao: 50.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Texiera, ARL, Montiero, PS, Rebelo, JM, et al. Emerging Infectious Diseases Jan-Feb 2000; 7(1). Available from: file://www.cdc.gov/ncidod/eid/vol7no1/texeira.htm",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_32_16901=[""].join("\n");
var outline_f16_32_16901=null;
var title_f16_32_16902="Complications of total knee arthroplasty";
var content_f16_32_16902=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Complications of total knee arthroplasty",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/32/16902/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/32/16902/contributors\">",
"     Gregory M Martin, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/32/16902/contributors\">",
"     Thomas S Thornhill, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/32/16902/contributors\">",
"     Jeffrey N Katz, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/32/16902/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/32/16902/contributors\">",
"     Daniel E Furst, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/32/16902/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/32/16902/contributors\">",
"     Paul L Romain, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?16/32/16902/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 8, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complications during and after total knee replacement are uncommon or rare and can often be prevented with meticulous surgical technique and with attentive postoperative management. As with other major surgery, complications may occur, and these include anesthesia-related risks, exacerbation of comorbid medical issues, and medication and allergic reactions.",
"   </p>",
"   <p>",
"    Complications related specifically to total knee arthroplasty, although uncommon, range from minor problems to devastating, life-threatening events. This topic discusses complications of total knee arthroplasty. The indications for, alternatives to, and surgical technique for total knee arthroplasty are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/6/17514?source=see_link\">",
"     \"Total knee arthroplasty\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     THROMBOEMBOLISM",
"    </span>",
"    &nbsp;&mdash;&nbsp;The development of deep venous thrombosis (DVT) with the potential to propagate a potentially lethal pulmonary embolus (PE) is the most feared complication of total knee arthroplasty. The reported incidence of DVT following total knee arthroplasty without prophylaxis ranges from 40 to 88 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16902/abstract/1\">",
"     1",
"    </a>",
"    ]. The incidences of asymptomatic PE, symptomatic PE, and mortality range from 10 to 20 percent, from 0.5 to 3 percent, and up to 2 percent, respectively.",
"   </p>",
"   <p>",
"    In contrast, the rates of inpatient venous thromboembolism (VTE) and PE among patients receiving prophylaxis following total or partial knee arthroplasty were much lower in estimates from a meta-analysis involving 23,475 patients in 26 randomized trials and observational studies [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16902/abstract/2\">",
"     2",
"    </a>",
"    ]. Venous thromboembolic events, symptomatic DVT, and PE occurred in 1.09 percent (95% CI 0.85-1.33), 0.63 percent (95% CI 0.47-0.78), and 0.27 percent (95% CI 0.16-0.38), respectively.",
"   </p>",
"   <p>",
"    The prevention, diagnosis, and treatment of DVT and PE after total joint arthroplasty (hip and knee) are discussed separately (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/52/41802?source=see_link\">",
"     \"Prevention of venous thromboembolic disease in surgical patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/30/35305?source=see_link\">",
"     \"Approach to the diagnosis and therapy of lower extremity deep vein thrombosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/57/6042?source=see_link\">",
"     \"Diagnosis of acute pulmonary embolism\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/4/43082?source=see_link\">",
"     \"Treatment of lower extremity deep vein thrombosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/32/42503?source=see_link\">",
"     \"Treatment of acute pulmonary embolism\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     INFECTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infection is another serious complication of total knee arthroplasty. The incidence of infection following total knee arthroplasty is low. As an example, one large study of 4171 knee arthroplasties found an infection rate of 1.6 percent using prophylactic antibiotics [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16902/abstract/3\">",
"     3",
"    </a>",
"    ]. Patients with diabetes are at increased risk of both superficial and deep postoperative infection when compared with nondiabetics [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16902/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The clinical manifestations, diagnosis, prevention, and treatment of infection following total knee arthroplasty are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/43/42680?source=see_link\">",
"     \"Clinical manifestations and diagnosis of prosthetic joint infections\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/34/28198?source=see_link\">",
"     \"Prevention of prosthetic joint infections\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/19/6457?source=see_link\">",
"     \"Treatment of prosthetic joint infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     PATELLOFEMORAL DISORDERS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patellofemoral complications, as a group, are considered to be the most common reason for reoperation after total knee arthroplasty. Patellofemoral complications include patellar instability, loosening of the patellar component, patellar component failure, patella fracture, patella clunk syndrome, and rupture of the extensor mechanism.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Patellofemoral instability",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patellofemoral instability may manifest as subluxation or dislocation of the patella. Incidence varies between 1 and 20 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16902/abstract/5\">",
"     5",
"    </a>",
"    ]. Diagnosis is made by standard radiographs including a tangential (eg, &ldquo;sunrise&rdquo; or Merchant) view of the patella. Occasionally, a computerized tomography (CT) scan is obtained to determine component position (the femoral component requires several degrees of external rotation to have proper patellofemoral tracking). Treatment depends upon the problem and may include a surgical release of tight lateral soft tissues, patellofemoral realignment procedures, or revision of malpositioned components.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Patellar component loosening",
"    </span>",
"    &nbsp;&mdash;&nbsp;Loosening of the patellar component may be associated with osteolysis or with migration of the prosthesis and is often secondary to another condition. Among the associated disorders are instability, fracture, component malposition, osteoporosis, avascular necrosis, and poor cement technique [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16902/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Diagnosis is made with standard radiographs. Asymptomatic patients are observed, and symptomatic patients may undergo revision.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Patellar component failure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patellar component failure was typically associated with metal-backed patella components. This failure-prone design has, for the most part, been abandoned in favor of prosthetic patellar components made entirely of polyethylene.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Patella fracture",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patella fracture had a reported incidence of 0.3 percent in one study of 2887 knees [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16902/abstract/6\">",
"     6",
"    </a>",
"    ]. Fracture may be related to prosthesis design and positioning, to surgical techniques, to avascular necrosis of the patella, to excessive knee flexion, or to trauma.",
"   </p>",
"   <p>",
"    Diagnosis is with standard radiographs. A tangential view of the patella is recommended in addition to routine antero-posterior (AP) and lateral views in order to detect sagittal (vertical) fractures that could be inapparent on AP and lateral views.",
"   </p>",
"   <p>",
"    Treatment depends upon the severity of the fracture, upon the status of patellar component (loose versus well-fixed), and upon the status of the extensor mechanism (ability to perform a straight leg raise indicates an intact extensor mechanism). Treatment may vary from nonoperative (well-fixed component, minimally displaced fracture, intact extensor mechanism) to open reduction and to internal fixation of the fracture with or without component revision.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Patella clunk",
"    </span>",
"    &nbsp;&mdash;&nbsp;The patella clunk syndrome, a clunk felt as the knee is actively extended from 60 to 30 degrees, results from formation of fibrous tissue on the quadriceps tendon. The syndrome was predominantly seen with early designs of posterior cruciate substituting prostheses. The incidence of patella clunk has decreased with changes in component design.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Extensor mechanism rupture",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rupture of the extensor mechanism (quadriceps or patellar tendon) is a feared complication but, fortunately, is rare. The major manifestation is an inability to actively extend the knee. Surgery is the treatment of choice; however, poor outcomes are normal [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16902/abstract/1\">",
"     1",
"    </a>",
"    ]. Patellar tendon rupture is a rare complication of knee arthroplasty. Surgical repair with autologous, allogeneic, or prosthetic tendon grafts may be necessary [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16902/abstract/7\">",
"     7",
"    </a>",
"    ]. Physiotherapy with a goal of maintaining knee extension and, thus, of minimizing the risk of developing an irreversible knee flexion contracture is recommended while awaiting reoperation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     PERONEAL NERVE PALSY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common neurologic complication after total knee arthroplasty is peroneal nerve palsy. Clinical manifestations include paresthesia, numbness, and extensor weakness (drop foot). Patients with severe valgus alignment in combination with a flexion deformity are at greatest risk.",
"   </p>",
"   <p>",
"    If noticed in the postoperative period, the surgical dressings are immediately loosened, and the knee is flexed to relieve pressure on the nerve. Nerve recovery is variable. As an example, one study found that 50 percent of episodes of peroneal palsy had a full recovery; patients with some residual nerve function recovered more often than those with complete palsies [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16902/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     ARTERIAL INJURIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vascular injuries in total knee arthroplasty are exceedingly rare. One survey of 147 surgeons documented only 14 arterial complications, the majority of which were thromboses [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16902/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     PERIPROSTHETIC FRACTURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fractures may occur around the femoral component, the tibial component, or the patella. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Patella fracture'",
"    </a>",
"    above.) Periprosthetic fractures occur more commonly in patients with osteoporosis (primary or secondary to glucocorticoids, disease, etc), with rheumatoid arthritis, and with stiff knees and may follow revision arthroplasty.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Femoral fractures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Supracondylar femoral fractures may have an association with notching of the anterior femur at the time of surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16902/abstract/10\">",
"     10",
"    </a>",
"    ]. Minimally displaced, well-aligned fractures with well-fixed components are treated nonoperatively with casting or bracing. Displaced fractures are reduced and fixed with plates and screws or with intramedullary rods. If the component is loose, it is revised.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Tibial fractures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tibial fractures around a total knee are rare. Like supracondylar femoral fractures, these are also treated nonoperatively or operatively depending upon the degree of displacement, the alignment, and the status of the implant.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     WOUND PROBLEMS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because of the thin soft tissue envelope around the knee, wound healing problems may occur and require prompt recognition and management to avoid severe complications, including infection and possible loss of the implant. Preoperative planning and evaluation of risk factors (rheumatoid arthritis, diabetes mellitus, obesity), especially in a knee with prior incisions, are critical. Persistent drainage should be treated by exclusion of infection with aspiration and cultures and by surgical irrigation and debridement. Plastic surgery consultation should be obtained, as needed, to ensure soft tissue coverage of the prosthesis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     POLYETHYLENE WEAR",
"    </span>",
"    &nbsp;&mdash;&nbsp;Wear is a normal phenomenon due to friction between the femoral component and the polyethylene of the tibial and patellar components. However, accelerated wear may occur because of patient-dependent factors (eg, activity level, weight), because of surgical technique (especially postoperative mechanical alignment), and because of prosthetic design and quality control issues.",
"   </p>",
"   <p>",
"    Patients may be asymptomatic or symptomatic, with pain, swelling, and increasing deformity in the knee. Diagnosis is made by plain radiographs, which may reveal joint space narrowing. Treatment may include continued observation, polyethylene liner exchange, or revision total knee arthroplasty if associated with component loosening.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     ASEPTIC FAILURE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Aseptic failure of total knee replacements may occur through several mechanisms, including polyethylene wear-induced osteolysis and component loosening (which may be due to osteolysis, excessive stress on components, poor fixation, poor component design, and other reasons). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/39/1658?source=see_link&amp;anchor=H23#H23\">",
"     \"Complications of total hip arthroplasty\", section on 'Osteolysis and wear'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Diagnosis is made by evidence of progressive radiolucency on serial radiographs. Bone scan may also play a role in the diagnosis. Most critical is ruling out the possibility of infection. Typically, aspiration of the joint for cell count, Gram stain, and cultures are performed. In addition, laboratory studies consisting of an erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) are obtained. Once infection is ruled out, the patient with symptomatic aseptic prosthetic failure may be a candidate for revision total knee arthroplasty.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5141112\">",
"    <span class=\"h1\">",
"     INSTABILITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Instability after knee replacement has been described as a significant factor which can lead to revision surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16902/abstract/11\">",
"     11",
"    </a>",
"    ]. Instability can occur in flexion, extension, or both.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5141119\">",
"    <span class=\"h1\">",
"     PERSISTENT PAIN AND DISSATISFACTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although outcomes after total knee replacement are generally good, many patients continue to report clinically significant pain",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    dissatisfaction. In one series of 1703 primary total knee replacements, 19 percent of patients were dissatisfied with their outcome [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16902/abstract/12\">",
"     12",
"    </a>",
"    ]. Similarly, in a systematic review of high-quality prospective studies of patients with osteoarthritis undergoing total knee replacement, about 20 percent of patients reported moderate to severe knee pain following surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16902/abstract/13\">",
"     13",
"    </a>",
"    ]. Efforts to identify the explanations for these suboptimal pain outcomes are an active area of research. Possible explanations for such persistent pain complaints include inappropriate expectations, technical failures of the procedure, pain from other sources, poor pain-coping skills, and others.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16754628\">",
"    <span class=\"h1\">",
"     STIFFNESS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stiffness, also called arthrofibrosis, is a postoperative limitation of range of motion that may result in functional impairment. Although there are no universally accepted criteria to diagnose stiffness, studies have shown that patients require the following amounts of knee flexion for different activities: 67&deg; to complete the",
"    <sup>",
"    </sup>",
"    swing phase of gait, 83&deg; to ascend stairs, 100&deg;",
"    <sup>",
"    </sup>",
"    to descend stairs, 93&deg; to rise from a standard chair, and",
"    <sup>",
"    </sup>",
"    up to 105&deg; to rise from a low chair [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16902/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. Stiffness may be caused by patient-related (preoperative) factors, by technical (intraoperative) factors, and by numerous postoperative factors (patient compliance with therapy, heterotopic bone, infection, pain syndromes). The best predictor of postoperative stiffness is preoperative range of motion [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16902/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Treatments include manipulation under anesthesia, arthroscopic lysis of adhesions, and revision knee replacement. Manipulation under anesthesia is safest and most effective if performed within the first three postoperative months. It remains controversial whether use of continuous passive motion may prevent stiffness. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/6/17514?source=see_link\">",
"     \"Total knee arthroplasty\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?28/50/29474?source=see_link\">",
"       \"Patient information: Knee replacement (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?21/13/21717?source=see_link\">",
"       \"Patient information: Total knee replacement (arthroplasty) (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3273584\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Complications during and after total knee replacement are uncommon or rare and can often be prevented with meticulous surgical technique and with attentive postoperative management. As with other major surgery, complications may occur, and these include anesthesia-related risks, exacerbation of comorbid medical issues, and medication and allergic reactions. Complications related specifically to total knee arthroplasty, although uncommon, range from minor problems to devastating, life-threatening events. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The development of deep venous thrombosis (DVT) with the potential to propagate a potentially lethal pulmonary embolus (PE) is the most feared complication of total knee arthroplasty. There is a significant incidence of DVT following total knee arthroplasty in patients who do not receive prophylaxis. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Thromboembolism'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Infection is another serious complication of total knee arthroplasty, although the incidence is low. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Infection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patellofemoral complications, the most common reason for reoperation after total knee arthroplasty, include patellar instability, loosening of the patellar component, patellar component failure, patella fracture, patella clunk syndrome, and rupture of the extensor mechanism. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Patellofemoral disorders'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The most common neurologic complication after total knee arthroplasty is peroneal nerve palsy. Clinical manifestations include paresthesia, numbness, and extensor weakness (drop foot). Patients with severe valgus alignment in combination with a flexion deformity are at greatest risk. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Peroneal nerve palsy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Fractures may occur around the femoral component, the tibial component, or the patella. Periprosthetic fractures occur more commonly in patients with osteoporosis, with rheumatoid arthritis, and with stiff knees and may follow revision arthroplasty. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Patella fracture'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H19\">",
"       'Periprosthetic fractures'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Wound healing problems occur because of the thin soft tissue envelope around the knee. They require prompt recognition and management to avoid severe complications including infection and possible loss of the implant. Preoperative planning and evaluation of risk factors (rheumatoid arthritis, diabetes mellitus, obesity), especially in a knee with prior incisions, are critical. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Wound problems'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Although wear is a normal phenomenon, accelerated wear may occur due to patient-dependent factors, due to surgical technique, and due to prosthetic design and quality control issues. Patients may be asymptomatic or symptomatic. Aseptic failure of total knee replacement has also been observed. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Polyethylene wear'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H24\">",
"       'Aseptic failure'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Up to one in five patients has persistent pain and is not satisfied after total knee arthroplasty. (See",
"      <a class=\"local\" href=\"#H5141119\">",
"       'Persistent pain and dissatisfaction'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Campbell's Operative Orthopaedics, 9th, Mosby, 1999.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16902/abstract/2\">",
"      Januel JM, Chen G, Ruffieux C, et al. Symptomatic in-hospital deep vein thrombosis and pulmonary embolism following hip and knee arthroplasty among patients receiving recommended prophylaxis: a systematic review. JAMA 2012; 307:294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16902/abstract/3\">",
"      Wilson MG, Kelley K, Thornhill TS. Infection as a complication of total knee-replacement arthroplasty. Risk factors and treatment in sixty-seven cases. J Bone Joint Surg Am 1990; 72:878.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16902/abstract/4\">",
"      Yang K, Yeo SJ, Lee BP, Lo NN. Total knee arthroplasty in diabetic patients: a study of 109 consecutive cases. J Arthroplasty 2001; 16:102.",
"     </a>",
"    </li>",
"    <li>",
"     Archibeck MJ, Berger RA, Garvin KL, et al. Orthopaedic Knowledge Update 7, Koval KJ (Ed), AAOS, 2002. p.517.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16902/abstract/6\">",
"      Brick GW, Scott RD. The patellofemoral component of total knee arthroplasty. Clin Orthop Relat Res 1988; :163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16902/abstract/7\">",
"      Mine T, Tanaka H, Taguchi T, et al. Patellar tendon rupture and marked joint instability after total knee arthroplasty. Arch Orthop Trauma Surg 2004; 124:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16902/abstract/8\">",
"      Asp JP, Rand JA. Peroneal nerve palsy after total knee arthroplasty. Clin Orthop Relat Res 1990; :233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16902/abstract/9\">",
"      Kumar SN, Chapman JA, Rawlins I. Vascular injuries in total knee arthroplasty. A review of the problem with special reference to the possible effects of the tourniquet. J Arthroplasty 1998; 13:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16902/abstract/10\">",
"      Aaron RK, Scott R. Supracondylar fracture of the femur after total knee arthroplasty. Clin Orthop Relat Res 1987; :136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16902/abstract/11\">",
"      Parratte S, Pagnano MW. Instability after total knee arthroplasty. J Bone Joint Surg Am 2008; 90:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16902/abstract/12\">",
"      Bourne RB, Chesworth BM, Davis AM, et al. Patient satisfaction after total knee arthroplasty: who is satisfied and who is not? Clin Orthop Relat Res 2010; 468:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16902/abstract/13\">",
"      Beswick AD, Wylde V, Gooberman-Hill R, et al. What proportion of patients report long-term pain after total hip or knee replacement for osteoarthritis? A systematic review of prospective studies in unselected patients. BMJ Open 2012; 2:e000435.",
"     </a>",
"    </li>",
"    <li>",
"     Kettelkamp D. Gait characteristics of the knee: Normal, abnormal, and post-reconstruction. In: American Academy of Orthopaedic Surgeons Symposium on Reconstructive Surgery of the Knee, CV Mosby, St. Louis 1978. p.47.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16902/abstract/15\">",
"      Laubenthal KN, Smidt GL, Kettelkamp DB. A quantitative analysis of knee motion during activities of daily living. Phys Ther 1972; 52:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16902/abstract/16\">",
"      Ritter MA, Stringer EA. Predictive range of motion after total knee replacement. Clin Orthop Relat Res 1979; :115.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7971 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-5D5ABCD1C5-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_32_16902=[""].join("\n");
var outline_f16_32_16902=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H3273584\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      THROMBOEMBOLISM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      INFECTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      PATELLOFEMORAL DISORDERS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Patellofemoral instability",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Patellar component loosening",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Patellar component failure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Patella fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Patella clunk",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Extensor mechanism rupture",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      PERONEAL NERVE PALSY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      ARTERIAL INJURIES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      PERIPROSTHETIC FRACTURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Femoral fractures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Tibial fractures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      WOUND PROBLEMS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      POLYETHYLENE WEAR",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      ASEPTIC FAILURE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5141112\">",
"      INSTABILITY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5141119\">",
"      PERSISTENT PAIN AND DISSATISFACTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16754628\">",
"      STIFFNESS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3273584\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/30/35305?source=related_link\">",
"      Approach to the diagnosis and therapy of lower extremity deep vein thrombosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/43/42680?source=related_link\">",
"      Clinical manifestations and diagnosis of prosthetic joint infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/39/1658?source=related_link\">",
"      Complications of total hip arthroplasty",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/57/6042?source=related_link\">",
"      Diagnosis of acute pulmonary embolism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?28/50/29474?source=related_link\">",
"      Patient information: Knee replacement (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?21/13/21717?source=related_link\">",
"      Patient information: Total knee replacement (arthroplasty) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/34/28198?source=related_link\">",
"      Prevention of prosthetic joint infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/52/41802?source=related_link\">",
"      Prevention of venous thromboembolic disease in surgical patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/6/17514?source=related_link\">",
"      Total knee arthroplasty",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/32/42503?source=related_link\">",
"      Treatment of acute pulmonary embolism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/4/43082?source=related_link\">",
"      Treatment of lower extremity deep vein thrombosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/19/6457?source=related_link\">",
"      Treatment of prosthetic joint infections",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_32_16903="DLBCL path";
var content_f16_32_16903=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F67243&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F67243&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Diffuse large B-cell lymphoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 292px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Diffuse large B-cell lymphoma. The majority of cases contain a mixture of large cells that resemble centroblasts with peripheral nucleoli and a minority of large cells that resemble immunoblasts with central nucleoli.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Armitage JO, Mauch PM, Harris NL, et al. Non-Hodgkin Lymphomas, 2nd ed, Lippincott Williams &amp; Wilkins, Philadelphia 2010. Copyright &copy; 2010 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_32_16903=[""].join("\n");
var outline_f16_32_16903=null;
var title_f16_32_16904="Penetrating trauma of the upper and lower genitourinary tract";
var content_f16_32_16904=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Penetrating trauma of the upper and lower genitourinary tract",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/32/16904/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/32/16904/contributors\">",
"     Michael S Runyon, MD, FAAEM, FACEP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/32/16904/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/32/16904/contributors\">",
"     Maria E Moreira, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/32/16904/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/32/16904/contributors\">",
"     Jonathan Grayzel, MD, FAAEM",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?16/32/16904/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 13, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Timely identification and management of penetrating genitourinary (GU) injuries minimize associated morbidity, which may include renal insufficiency, urinary incontinence, and sexual dysfunction. Prompt injury identification depends upon a systematic evaluation with consideration of the mechanism of injury, pertinent physical examination findings, analysis of the urine, and appropriate diagnostic imaging performed in the correct sequence.",
"   </p>",
"   <p>",
"    Ideally, in stable patients, the investigation for GU injury is conducted in a retrograde fashion beginning with evaluation of the external genitalia. The upper GU tract (ureters and kidneys) is evaluated after injury to the lower tract (bladder and urethra) is excluded, or after initiation of appropriate emergency management for an identified lower tract injury.",
"   </p>",
"   <p>",
"    Except in rare instances (eg, shattered kidney or major renal vascular laceration), GU injuries seldom pose a threat to life. As such, in the multiply injured or unstable patient, evaluation for GU injury is deferred until other, potentially life-threatening, injuries are excluded, and the patient is stabilized.",
"   </p>",
"   <p>",
"    The assessment and initial management of penetrating injuries to the upper and lower genitourinary tract are reviewed here. Blunt GU injuries, including straddle injuries, and other aspects of trauma management are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/63/18425?source=see_link\">",
"     \"Blunt genitourinary trauma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/53/35669?source=see_link\">",
"     \"Straddle injuries\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 10 percent of trauma patients sustain injury to the genitourinary (GU) system. Of these, approximately 15 percent are due to a penetrating mechanism, most commonly gunshot or stab wounds [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16904/abstract/1\">",
"     1",
"    </a>",
"    ]. With the exception of a shattered kidney or major renal vascular laceration with significant hemorrhage, penetrating genitourinary injury is rarely life-threatening.",
"   </p>",
"   <p>",
"    Up to two thirds of cases of GU trauma involve the external genitalia. The majority of patients with penetrating penile trauma have other nongenitourinary injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16904/abstract/2\">",
"     2",
"    </a>",
"    ]. Urethral injuries frequently occur coincidentally with testicular trauma; gunshot wounds represent the most common mechanism. Penetrating trauma is responsible for up to 45 percent of all bladder injuries, and associated injury to the buttocks, bowel, and rectum are common [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16904/abstract/3,4\">",
"     3,4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Ureteral injuries are rare. In adults, penetrating injuries account for approximately 90 percent of cases and most commonly involve gunshot wounds [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16904/abstract/5-7\">",
"     5-7",
"    </a>",
"    ]. Nearly all cases of penetrating ureteral trauma are associated with additional injuries, most commonly to the gastrointestinal tract, abdominal or pelvic vasculature, kidney, and bladder [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16904/abstract/5-8\">",
"     5-8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    While only 5 to 10 percent of kidney injuries are due to penetrating trauma, they tend to be more severe than blunt injuries and are associated with a nephrectomy rate of up to 33 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16904/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ANATOMY, PHYSIOLOGY, AND MECHANISM",
"    </span>",
"    &nbsp;&mdash;&nbsp;The anatomy and physiology of the genitourinary system are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/63/18425?source=see_link&amp;anchor=H3#H3\">",
"     \"Blunt genitourinary trauma\", section on 'Anatomy, physiology, and mechanism'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Penetrating injuries to the upper or lower genitourinary tract may be inflicted by gunshots, knives, shrapnel, or other sharp objects. Additionally, the skin of the penis, scrotum, or labia may become ensnared by a metal zipper or injured through self-mutilation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/25/30100?source=see_link\">",
"     \"Management of zipper injuries\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PREHOSPITAL MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prehospital management of the patient with penetrating genitourinary trauma should focus on identification and stabilization of any potential life threats, beginning with the airway, breathing, and circulation. Prehospital trauma management is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/4/17482?source=see_link\">",
"     \"Prehospital care of the adult trauma patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Often a trauma history is incomplete or difficult to obtain and signs of penetrating trauma may not be obvious. Therefore, a meticulous physical examination is crucial to avoid missing occult injuries. Whenever a penetrating force is judged to have been inflicted in proximity to a portion of the genitourinary tract, an evaluation of potentially injured structures using radiographic imaging is necessary. The presence of gross or microscopic hematuria is a concerning but unreliable sign because it is frequently absent in cases of significant penetrating genitourinary trauma and, when present, does not correlate with the severity of injury. Diagnostic testing is discussed below. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Approach to testing'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H9\">",
"     'Diagnostic tests'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       External genitalia injury",
"      </strong>",
"      &ndash; Signs of penetrating injury to the external genitalia may not be obvious but can include a perineal, scrotal, penile, or labial hematoma, or injuries to adjacent structures, such as the proximal thigh or buttocks. It is important to conduct a careful and complete physical examination looking for associated and occult injuries. In one series, 80 percent of gunshot wounds to the penis were associated with injury to other structures, most commonly the upper thigh and scrotum [",
"      <a class=\"abstract\" href=\"UTD.htm?16/32/16904/abstract/10\">",
"       10",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Penetrating injury of the external genitalia may cause disruption of the tunica albuginea. This can lead to the accumulation of blood or fluid between the tunica albuginea and tunica vaginalis, resulting in a hematocele or hydrocele respectively.",
"      <br/>",
"      <br/>",
"      Violation of the corpora cavernosa requires operative intervention and is heralded by an expanding penile hematoma, significant bleeding from a wound to the penile shaft, or a palpable corporal defect.",
"      <br/>",
"      <br/>",
"      Whenever blood or hematoma is found at the introitus or the injuring force occurs in proximity to the vagina, a meticulous vaginal examination is mandatory. The complications of missed vaginal injuries include infection, fistula formation, and significant hemorrhage [",
"      <a class=\"abstract\" href=\"UTD.htm?16/32/16904/abstract/11,12\">",
"       11,12",
"      </a>",
"      ]. In one series, 25 percent of women sustaining injury of the external genitalia required red cell transfusion due to blood loss from genital injuries alone [",
"      <a class=\"abstract\" href=\"UTD.htm?16/32/16904/abstract/11\">",
"       11",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Trauma to the lower genital tract in women, including injuries sustained from sexual assault, is reviewed in greater detail separately. Genital injuries in children sustained via sexual abuse are also reviewed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/2/44071?source=see_link&amp;anchor=H2#H2\">",
"       \"Evaluation and management of lower genital tract trauma in women\", section on 'Etiology'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/2/44071?source=see_link&amp;anchor=H6#H6\">",
"       \"Evaluation and management of lower genital tract trauma in women\", section on 'Physical examination'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/27/35258?source=see_link\">",
"       \"Evaluation of sexual abuse in children and adolescents\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Urethra and bladder injuries",
"      </strong>",
"      &ndash; Urethral injuries are far more common in males; the brevity of the female urethra makes injury unlikely. Injuries may include contusion, partial disruption, and complete transection. Signs of injury include blood at the penile meatus, scrotal swelling or hematoma, perineal ecchymosis, and an abnormally positioned prostate on digital rectal examination. As these clinical features are variably present in penetrating trauma, clinicians should suspect and evaluate for urethral disruption whenever the wound or trajectory occurs in proximity to the course of the urethra. Likewise, an evaluation for bladder rupture is indicated in the presence of gross hematuria or whenever the injury trajectory occurs in proximity to the bladder.",
"     </li>",
"     <li>",
"      <strong>",
"       Upper genitourinary tract injury",
"      </strong>",
"      &ndash; Penetrating ureteral injuries are uncommon and the diagnosis is frequently missed on the initial evaluation as the signs and symptoms are minimal and nonspecific. Delayed findings include fever, flank pain, and a palpable flank mass (urinoma). Urinoma is seen in up to 30 percent of patients after penetrating trauma [",
"      <a class=\"abstract\" href=\"UTD.htm?16/32/16904/abstract/13\">",
"       13",
"      </a>",
"      ]. Consider this injury in any penetrating trauma with a trajectory in proximity to the ureter. Hematuria (gross or microscopic) is",
"      <strong>",
"       NOT",
"      </strong>",
"      a reliable predictor of ureteral injury as urinalysis is normal (&lt;5",
"      <span class=\"nowrap\">",
"       RBC/HPF)",
"      </span>",
"      approximately 25 percent of the time [",
"      <a class=\"abstract\" href=\"UTD.htm?16/32/16904/abstract/5,6\">",
"       5,6",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Urinalysis'",
"      </a>",
"      below.)",
"      <br/>",
"      <br/>",
"      Clinical signs of renal injury include ecchymosis, pain, or tenderness at the flank or abdomen, rib or spine fractures adjacent to the kidney, gross hematuria, abdominal organ injury, and shock. In penetrating trauma, these clinical features are variably present and renal involvement must be suspected in all cases when the injury trajectory occurs in proximity to the kidney. Greater than 90 percent of patients will have other, associated injuries with the majority of these being intraabdominal. Note that hematuria is",
"      <strong>",
"       absent",
"      </strong>",
"      in greater than 50 percent of penetrating renal injuries [",
"      <a class=\"abstract\" href=\"UTD.htm?16/32/16904/abstract/14\">",
"       14",
"      </a>",
"      ]. Renal injuries are graded from I to V according to the American Association for the Surgery of Trauma organ injury severity scale for the kidney, and range from minor contusions (Grade I) to major vascular disruptions (Grade V) (",
"      <a class=\"graphic graphic_figure graphicRef57943 \" href=\"UTD.htm?29/5/29784\">",
"       figure 1",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?16/32/16904/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     PRIMARY EVALUATION AND MANAGEMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Initial assessment",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial assessment of the patient with penetrating genitourinary (GU) trauma should focus on the rapid identification and stabilization of life-threatening injuries. Except in the rare instance of a shattered kidney or major renal vascular laceration with significant hemorrhage, GU injuries seldom pose an immediate threat to life. Moreover, GU injuries seldom occur in isolation; associated injuries are usually intraabdominal. General evaluation of the trauma patient is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/11/35002?source=see_link\">",
"     \"Initial management of trauma in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Therefore, in the multiply injured or unstable patient, evaluation for GU trauma is deferred until other potentially life-threatening injuries are excluded and the patient is stabilized. During the initial assessment, note any findings that may herald GU injury, and perform appropriate studies once immediate life threats have been addressed. In the interim, apply dressings to open wounds and control hemorrhage with direct pressure. Provide isotonic intravenous fluids, analgesics, and tetanus immunization as needed. Give nothing to the patient by mouth until the need for operative intervention has been excluded.",
"   </p>",
"   <p>",
"    When possible, obtain a focused history of the injury from the patient, prehospital personnel, and available bystanders. Important information includes the type of weapon (eg, size, caliber), the number and location of the wounds, any history of genitourinary injury or disease, current medications, allergies, and tetanus immunization status.",
"   </p>",
"   <p>",
"    During the secondary survey, perform a careful examination of the abdomen, pelvis, and external genitalia, and note signs of possible GU injury. Pay close attention to the perineum, gluteal clefts, back, and flanks as wounds may be small and hidden by skin folds. Note the size, location, and apparent trajectory of any wounds.",
"   </p>",
"   <p>",
"    The digital rectal examination may provide valuable information in the penetrating trauma patient, especially in the presence of wounds to the external genitalia, buttocks, pelvis, lower abdomen, and upper thigh. First, upon inserting the well-lubricated, gloved finger, make note of the rectal tone. Decreased tone may be seen in patients with spinal cord injuries or those who have received neuromuscular blocking agents. Next, palpate anteriorly to identify the midline and two lobes of the prostate. An absent or \"high riding\" prostate indicates a posterior urethral disruption until proven otherwise. Next, sweep your finger around the entire circumference of the rectal vault feeling for lacerations or bone fragments. Finally, remove your finger and examine it for the presence of gross blood. To prevent false positives during this last step, ensure that the glove is free of blood prior to insertion. The clinician should take care to avoid injuring their own finger from bone fragments in patients with potential bony injury from a gunshot or explosion.",
"   </p>",
"   <p>",
"    While most patients with pelvic trauma receive a digital rectal examination, the vaginal examination is often erroneously omitted. To avoid missing occult injuries that may result in significant and potentially life-threatening hemorrhage and infection, perform a careful vaginal examination to assess for lacerations or bone fragments in all injured women with penetrating injury occurring in proximity to the pelvis.",
"   </p>",
"   <p>",
"    The diagnosis of injuries to the external genitalia is largely based upon the mechanism of injury and the physical examination. Consider concomitant urethral injury and perform a retrograde urethrogram to assess for urethral integrity in any male with penetrating trauma that violates Buck's fascia or when there is blood or hematoma at the urethral meatus.",
"   </p>",
"   <p>",
"    Trauma to the lower genital tract in women, including injuries sustained from sexual assault, is reviewed in greater detail separately. Genital injuries in children sustained via sexual abuse are also reviewed separately. A complete examination of the traumatized lower GU tract of an infant or child may need to be performed by a clinician with suitable expertise under general anaesthesia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/2/44071?source=see_link&amp;anchor=H2#H2\">",
"     \"Evaluation and management of lower genital tract trauma in women\", section on 'Etiology'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/2/44071?source=see_link&amp;anchor=H6#H6\">",
"     \"Evaluation and management of lower genital tract trauma in women\", section on 'Physical examination'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/27/35258?source=see_link\">",
"     \"Evaluation of sexual abuse in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Approach to testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ideally, in stable patients investigation for penetrating genitourinary injury is conducted in a retrograde fashion beginning with the evaluation of the external genitalia and urethra prior to that of the bladder. The ureters and kidneys (upper genitourinary tract) are evaluated after lower tract injury is excluded, or after initiation of appropriate emergency management for an identified lower tract injury.",
"   </p>",
"   <p>",
"    In cases of suspected urethral injury, it is imperative to evaluate the integrity of the urethra prior to attempting placement of a Foley (ie, urinary) catheter to avoid worsening a partial disruption. This is accomplished by retrograde urethrogram. However, the procedure is deferred when diagnostic and potentially therapeutic pelvic angiography is to be undertaken for the purpose of controlling pelvic hemorrhage by embolization. In these cases, extravasated contrast dye from the retrograde urethrogram may obscure angiography images thereby interfering with study interpretation and embolization attempts. The role of angiography in the management of pelvic trauma is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/7/22650?source=see_link\">",
"     \"Pelvic trauma: Initial evaluation and management\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In the presence of gross hematuria without other signs of urethral injury, it is reasonable to make one attempt at passing a urinary catheter. If resistance is encountered, abort the attempt and investigate urethral integrity by retrograde urethrography. Placement and management of urinary catheters is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/47/40697?source=see_link\">",
"     \"Placement and management of urinary bladder catheters\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Evaluate all patients with gross hematuria or injuries in proximity to the bladder for bladder rupture [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16904/abstract/3,16\">",
"     3,16",
"    </a>",
"    ]. This is accomplished by retrograde cystography or retrograde CT cystography. In the hemodynamically stable patient with suspected renal injury, contrast enhanced CT scanning is indicated to evaluate for the presence and extent of the injury. The performance of the tests used to assess genitourinary injury is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/63/18425?source=see_link&amp;anchor=H9#H9\">",
"     \"Blunt genitourinary trauma\", section on 'Diagnostic tests'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The diagnosis of ureteral injury is elusive. Intravenous pyelography (IVP) was the traditional test of choice, although the reported sensitivity is highly variable [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16904/abstract/5,6,8\">",
"     5,6,8",
"    </a>",
"    ]. CT imaging has gained popularity and is generally used to identify ureteral and related nongenitourinary injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16904/abstract/9,17\">",
"     9,17",
"    </a>",
"    ]. Delayed CT images are required to allow time for the intravenous contrast to be excreted by the kidneys. If operative exploration is indicated, the ureters may be directly evaluated in the surgical suite. When the diagnosis remains in doubt, retrograde pyelography may be of use.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Diagnostic tests",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Urinalysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hematuria is an important marker of injury to the genitourinary tract. However, unlike select cases involving blunt mechanisms, the absence of hematuria (gross or microscopic) is not sufficiently sensitive to exclude penetrating genitourinary injury. It is important to inspect the initial urine output to avoid missing transient hematuria that may clear with ongoing fluid resuscitation. A spontaneously voided specimen is ideal, but is frequently impractical in the multiply injured patient.",
"   </p>",
"   <p>",
"    Gross hematuria is defined as urine that is any color other than clear or yellow. This conservative definition is necessary because the degree of gross hematuria often does not correlate with the severity of injury; a relatively minor urethral injury may result in frank hemorrhage while major vascular disruption may present with only slightly discolored urine.",
"   </p>",
"   <p>",
"    False positives may result from many factors, including ingestion of certain foods or dyes, select medications, or the presence of free myoglobin due to rhabdomyolysis. Microscopic hematuria is defined as greater than five red blood cells per high powered field",
"    <span class=\"nowrap\">",
"     (RBCs/HPF)",
"    </span>",
"    or a positive urine dipstick test.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Plain x-rays",
"    </span>",
"    &nbsp;&mdash;&nbsp;After the initial assessment and stabilization, and depending upon the specific mechanism of injury, plain AP and lateral radiographs may be useful in localizing any retained missiles and determining the trajectory of the injuring force. Placement of a radiopaque marker at the site(s) of external injury is helpful, particularly in cases of gunshot wounds or shotgun blasts.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Ultrasound",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the injured patient, ultrasound is used primarily to detect free intraperitoneal fluid, which is a marker for visceral injury. While ultrasound is useful for detecting such fluid, it cannot distinguish among the different types (eg, blood, urine, or ascites). In addition, ultrasound does not reliably exclude injury to the kidneys, ureters, or bladder [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16904/abstract/1\">",
"     1",
"    </a>",
"    ]. Therefore, while ultrasound imaging may provide useful information in the assessment of a patient with suspected penile or scrotal injury, its role in the overall assessment of penetrating genitourinary trauma is limited.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Retrograde urethrogram",
"    </span>",
"    &nbsp;&mdash;&nbsp;In cases of possible urethral injury, it is imperative to evaluate the integrity of the urethra before attempting placement of a Foley catheter in order to avoid worsening a partial disruption. A retrograde urethrogram is performed for this purpose. However, the procedure is deferred if pelvic angiography is to be performed. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Approach to testing'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    In the presence of gross hematuria without other signs of urethral injury, it is reasonable to make one attempt at passing a urinary catheter. If resistance is encountered, abort the attempt and investigate urethral integrity. Performance of the retrograde urethrogram is described separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/63/18425?source=see_link&amp;anchor=H12#H12\">",
"     \"Blunt genitourinary trauma\", section on 'Retrograde urethrogram'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Retrograde cystogram",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once a Foley catheter has been placed, patients with a suspected bladder injury are assessed with a retrograde cystogram or retrograde CT cystography. Performance of the retrograde cystogram is described separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/63/18425?source=see_link&amp;anchor=H13#H13\">",
"     \"Blunt genitourinary trauma\", section on 'Retrograde cystogram'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     CT scanning",
"    </span>",
"    &nbsp;&mdash;&nbsp;Computed tomography (CT) scanning with intravenous contrast enhancement is the modality of choice for the staging of penetrating renal trauma in the hemodynamically stable patient and for the assessment of genitourinary trauma generally [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16904/abstract/9,17,18\">",
"     9,17,18",
"    </a>",
"    ]. The initial CT frequently misses injuries to the renal pelvis and ureters, and additional images, obtained 10 minutes after the bolus of IV contrast is given, are indicated to assess for contrast extravasation when these injuries are suspected. In patients undergoing CT scanning of other organ systems, suspected bladder injuries may be investigated with CT cystography after retrograde filling of the bladder [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16904/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     IV pyelography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intravenous pyelography (IVP) has long been the test of choice for evaluating the ureters, but it is time consuming and its reported sensitivity is highly variable [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16904/abstract/5,6,8\">",
"     5,6,8",
"    </a>",
"    ]. CT has largely supplanted IVP as the imaging modality of choice for suspected renal trauma, but IVP may still be useful in select cases, such as suspected ureteral injury when delayed CT images are nondiagnostic.",
"   </p>",
"   <p>",
"    The so-called \"single shot IVP\" is rarely indicated in the emergency department evaluation of suspected penetrating renal trauma, but may be used occasionally at the discretion of the consulting urologist. The main indication is to confirm the presence of a functioning contralateral kidney in a patient deemed too unstable for transport to the CT scanner. However, this study certainly should not delay transfer to the operating suite in such cases. The procedure is performed by rapidly injecting 2",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    of intravenous contrast material and then obtaining a KUB x-ray 10 minutes later [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16904/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Retrograde pyelography",
"    </span>",
"    &nbsp;&mdash;&nbsp;In select cases, such as suspected ureteral injury when other imaging modalities are nondiagnostic, the operating urologist may elect to perform cystoscopy with retrograde pyelography.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     SUBSEQUENT MANAGEMENT AND CONSULTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;After life-threatening injury has been excluded, appropriate management and consultation are performed for genitourinary injuries. Superficial lacerations to the scrotum or penis should be copiously irrigated and closed with absorbable sutures. The management of zipper entrapment injuries is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/25/30100?source=see_link\">",
"     \"Management of zipper injuries\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An amputated penis should be wrapped in saline moistened gauze and placed in a sealed plastic bag, which is then placed on ice in a second plastic bag (this prevents direct contact between the penis and ice) until reimplantation. Reimplantation of an amputated penis should be performed as expeditiously as possible, but has been successful after 16 hours of cold ischemia (ie, ischemia in appropriately cooled tissue) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16904/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If a urethral injury is suspected subsequent to successful placement of a bladder (Foley) catheter, do not remove the catheter. A retrograde urethrogram may be obtained by inserting a small feeding tube alongside the catheter. Urology consultation is indicated for management of patients with an abnormal retrograde urethrogram or in cases of suspected urethral injury when a retrograde urethrogram cannot be obtained. In females with a suspected urethral injury, urologic consultation is necessary to determine whether diagnostic ureteroscopy should be performed. Differences in the urethral anatomy of females make retrograde urethrography technically challenging and therefore it is not recommended [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16904/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    With bladder injuries, the primary goal is to keep the bladder completely decompressed. If urethral injury is excluded, place a Foley catheter and irrigate the bladder as needed to clear any clots and ensure adequate drainage. Placement and management of urinary catheters is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/47/40697?source=see_link\">",
"     \"Placement and management of urinary bladder catheters\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Because bladder injuries are frequently associated with intraabdominal trauma, a diligent search for additional injuries should be undertaken in all patients with an abnormal cystogram. When undertaking this search, keep in mind that ultrasound cannot distinguish between blood and urine. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/30/12776?source=see_link\">",
"     \"Initial evaluation and management of abdominal stab wounds in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/54/3943?source=see_link\">",
"     \"Initial evaluation and management of abdominal gunshot wounds in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    With upper genitourinary tract injuries, identification and urologic consultation are the priorities of emergent management. In cases of major renal vascular injury, emergent angiography with selective embolization can be both diagnostic and therapeutic. However, the procedure is time consuming, requires specialized equipment, and is not available in all centers.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     PITFALLS OF MANAGEMENT",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Delaying transfer to definitive care to obtain imaging studies in the hemodynamically unstable patient.",
"     </li>",
"     <li>",
"      Missing significant injuries due to failure to perform careful rectal and vaginal examinations in patients with penetrating trauma in proximity to the pelvis.",
"     </li>",
"     <li>",
"      Relying on the absence of hematuria to exclude significant penetrating genitourinary injury.",
"     </li>",
"     <li>",
"      Completing a partial urethral disruption by attempting Foley catheter placement prior to ensuring urethral integrity with a retrograde urethrogram in a patient with signs of urethral injury. (In the presence of gross hematuria without other signs of urethral injury, it is reasonable to make one attempt at passing a urinary catheter. If resistance is encountered, abort the attempt and investigate urethral integrity.)",
"     </li>",
"     <li>",
"      Missing significant bladder injuries by clamping the Foley catheter and relying on passive filling of the bladder by intravenously administered contrast prior to CT cystography. An adequate study requires retrograde filling to distend the bladder. The performance of the tests used to assess genitourinary injury is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/63/18425?source=see_link&amp;anchor=H9#H9\">",
"       \"Blunt genitourinary trauma\", section on 'Diagnostic tests'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     DEFINITIVE MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients with significant genitourinary injuries require urgent or emergent urologic consultation in the emergency department. Many such patients have associated nonurologic (usually intraabdominal) injuries that require management by trauma surgeons. In the event that appropriate specialists are unavailable, expeditious transfer to a referral center is indicated after the initial assessment and stabilization.",
"   </p>",
"   <p>",
"    All but the most superficial penetrating injuries to the external genitalia require operative exploration, especially those that violate the corpora cavernosa. Reimplantation of an amputated penis should be performed as expeditiously as possible, but has been successful after 16 hours of cold ischemia [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16904/abstract/2\">",
"     2",
"    </a>",
"    ]. The majority of women with vaginal injuries require operative repair or washout to prevent significant morbidity and possible mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16904/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The optimal definitive management of urethral injuries depends upon several factors, including the location (anterior or posterior) and severity (partial or complete) of the injury, and the preference and expertise of the consulting urologist. Options vary from simple placement of a Foley catheter, which allows a partial anterior urethral injury to heal by secondary intention, to early endoscopic realignment or delayed urethroplasty of posterior urethral injuries. Often, placement of a suprapubic cystostomy tube will be required to promote decompression of the bladder and divert urine from the healing urethral injury or anastomosis. Regardless of the approach, the ultimate goal is the maintenance of urinary continence and sexual function.",
"   </p>",
"   <p>",
"    Operative repair is indicated in most cases of penetrating bladder injury. Depending upon the degree and location of ureteral injury, management options include cystoscopic stent placement or surgical repair over a stent. Urinary diversion may be required.",
"   </p>",
"   <p>",
"    Definitive management of penetrating renal trauma depends upon the specific pattern and severity of injury. As with blunt mechanisms, penetrating injuries may be classified according to the American Association for the Surgery of Trauma (AAST) organ injury severity scale for the kidney (",
"    <a class=\"graphic graphic_figure graphicRef57943 \" href=\"UTD.htm?29/5/29784\">",
"     figure 1",
"    </a>",
"    ). A study of 9344 renal injuries, including 18 percent due to a penetrating mechanism, demonstrated an increase in mortality, rate of operative intervention, total length of stay, and length of ICU stay with increasing injury severity as determined by the AAST organ injury severity scale for the kidney [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16904/abstract/22\">",
"     22",
"    </a>",
"    ]. Another study of 8465 renal injuries (19 percent penetrating) found that among those injured by a penetrating mechanism increasing severity (AAST grades 3 to 5) was associated with an increased nephrectomy rate [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16904/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most patients with penetrating renal injuries who are hemodynamically stable without evidence of progressive blood loss or urinary extravasation may be managed nonoperatively; however, renal injuries inflicted by gunshot wounds are at increased risk of complications and the threshold for operative intervention is generally lower in these patients, reinforcing the need for prompt consultation with a urologic surgeon. Delayed nephrectomy may be indicated in the small subset of patients who develop hypertension or symptomatic renal infarction [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16904/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A minority of hemodynamically stable patients with no other indications for admission may be considered for discharge from the emergency department after telephone consultation with the urologist assuming responsibility for follow-up care. Such cases include minor lacerations and zipper injuries not requiring formal wound exploration and minor, isolated, partial injuries of the anterior urethra in the presence of a functioning Foley catheter. Counsel these patients on the signs and symptoms of infection and Foley catheter dysfunction, and tell them to return to the ED if they develop these or any other concerning symptoms. Finally, ensure that they understand the importance of complying with the scheduled follow-up plan.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     OUTCOMES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Timely recognition and appropriate treatment of penetrating genitourinary trauma are paramount to minimizing associated morbidity. Early complications include bleeding, infection, abscess formation, urinary extravasation and fistulas, and urinoma formation.",
"   </p>",
"   <p>",
"    Delayed complications include bleeding, hydronephrosis, calculus formation, chronic pyelonephritis, hypertension, arteriovenous fistulas, pseudoaneurysms, urethral strictures, urinary incontinence, and sexual dysfunction. Renal failure may occur, most commonly in patients requiring unilateral nephrectomy secondary to hemodynamic instability. A subset of patients will require short-term renal replacement therapy, but the vast majority will regain sufficient renal function to avoid long-term dialysis [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16904/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hypertension may occur following renal trauma, although the rates given for this complication vary considerably among case series [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16904/abstract/13\">",
"     13",
"    </a>",
"    ]. Transient hypertension is seen in up to ten percent of patients, but generally resolves within several weeks. Chronic hypertension may occur within days or up to several years following renal injury.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Injury identification, appropriate consultation, and supportive care are the mainstays of the emergent management of penetrating genitourinary (GU) injuries. With the exception of a shattered kidney or major renal vascular laceration with significant hemorrhage, penetrating GU injury is rarely life-threatening. Assessment is based upon the mechanism of injury, examination findings, urinalysis, and diagnostic imaging. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Initial assessment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Signs of penetrating injury to the external genitalia may not be obvious but can include a perineal, scrotal, penile, or labial hematoma, or injuries to adjacent structures, such as the proximal thigh or buttocks. It is important to perform a careful physical examination looking for associated and occult injuries. Digital rectal and vaginal examinations should be performed whenever there is an injury in proximity to the pelvis (and should be performed cautiously if there is suspicion of pelvic fracture fragments). Hematuria increases the probability of penetrating GU injuries, but its absence does",
"      <strong>",
"       NOT",
"      </strong>",
"      exclude them. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Clinical features'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H7\">",
"       'Initial assessment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Testing for penetrating GU injury is indicated when there are clinical signs of trauma or the injury trajectory courses in proximity to the GU tract. In stable patients, imaging studies are performed in retrograde fashion beginning with the evaluation of the external genitalia and urethra prior to that of the bladder. Evaluate the ureters and kidneys after lower tract injury is excluded, or after initiation of appropriate emergency management for an identified lower tract injury. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Approach to testing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      If signs of penile or urethral injury are present, perform a retrograde urethrogram prior to insertion of a Foley catheter. In cases of gross hematuria or injury proximate to the urethra, obtain a retrograde cystogram or retrograde CT cystogram to evaluate the bladder. Following evaluation for lower tract injury, suspected upper tract injury is assessed with contrast enhanced CT scan, including delayed images to evaluate possible collecting system involvement.",
"     </li>",
"     <li>",
"      Most patients with significant GU injuries require urgent or emergent urologic consultation. Many such patients have associated nonurologic injuries (usually intraabdominal) that require assessment by trauma surgery. Expeditious transfer is necessary after the initial assessment and stabilization when specialist care is not available. Do not delay transfer to definitive care to obtain imaging studies in unstable patients. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Subsequent management and consultation'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H20\">",
"       'Definitive management'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1993320\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;We are saddened by the untimely death of John Marx, MD, who passed away in July 2012. We wish to acknowledge Dr. Marx's dedication and his many contributions to UpToDate, in particular, his work as editor-in-chief for Emergency Medicine and as a section editor and author for Adult Trauma.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16904/abstract/1\">",
"      Jankowski JT, Spirnak JP. Current recommendations for imaging in the management of urologic traumas. Urol Clin North Am 2006; 33:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16904/abstract/2\">",
"      Bandi G, Santucci RA. Controversies in the management of male external genitourinary trauma. J Trauma 2004; 56:1362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16904/abstract/3\">",
"      Gomez RG, Ceballos L, Coburn M, et al. Consensus statement on bladder injuries. BJU Int 2004; 94:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16904/abstract/4\">",
"      Cinman NM, McAninch JW, Porten SP, et al. Gunshot wounds to the lower urinary tract: a single-institution experience. J Trauma Acute Care Surg 2013; 74:725.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16904/abstract/5\">",
"      Elliott SP, McAninch JW. Ureteral injuries from external violence: the 25-year experience at San Francisco General Hospital. J Urol 2003; 170:1213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16904/abstract/6\">",
"      Carver BS, Bozeman CB, Venable DD. Ureteral injury due to penetrating trauma. South Med J 2004; 97:462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16904/abstract/7\">",
"      Best CD, Petrone P, Buscarini M, et al. Traumatic ureteral injuries: a single institution experience validating the American Association for the Surgery of Trauma-Organ Injury Scale grading scale. J Urol 2005; 173:1202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16904/abstract/8\">",
"      Perez-Brayfield MR, Keane TE, Krishnan A, et al. Gunshot wounds to the ureter: a 40-year experience at Grady Memorial Hospital. J Urol 2001; 166:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16904/abstract/9\">",
"      Lynch TH, Mart&iacute;nez-Pi&ntilde;eiro L, Plas E, et al. EAU guidelines on urological trauma. Eur Urol 2005; 47:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16904/abstract/10\">",
"      Hall SJ, Wagner JR, Edelstein RA, Carpinito GA. Management of gunshot injuries to the penis and anterior urethra. J Trauma 1995; 38:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16904/abstract/11\">",
"      Goldman HB, Idom CB Jr, Dmochowski RR. Traumatic injuries of the female external genitalia and their association with urological injuries. J Urol 1998; 159:956.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16904/abstract/12\">",
"      Lev RY, Mor Y, Golomb J, et al. Missed female urethral injury complicated by myonecrosis of the thigh. J Urol 2001; 165:1216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16904/abstract/13\">",
"      Al-Qudah HS, Santucci RA. Complications of renal trauma. Urol Clin North Am 2006; 33:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16904/abstract/14\">",
"      Kansas BT, Eddy MJ, Mydlo JH, Uzzo RG. Incidence and management of penetrating renal trauma in patients with multiorgan injury: extended experience at an inner city trauma center. J Urol 2004; 172:1355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16904/abstract/15\">",
"      Santucci RA, McAninch JW, Safir M, et al. Validation of the American Association for the Surgery of Trauma organ injury severity scale for the kidney. J Trauma 2001; 50:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16904/abstract/16\">",
"      Hsieh CH, Chen RJ, Fang JF, et al. Diagnosis and management of bladder injury by trauma surgeons. Am J Surg 2002; 184:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16904/abstract/17\">",
"      Ramchandani P, Buckler PM. Imaging of genitourinary trauma. AJR Am J Roentgenol 2009; 192:1514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16904/abstract/18\">",
"      Srinivasa RN, Akbar SA, Jafri SZ, Howells GA. Genitourinary trauma: a pictorial essay. Emerg Radiol 2009; 16:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16904/abstract/19\">",
"      Vaccaro JP, Brody JM. CT cystography in the evaluation of major bladder trauma. Radiographics 2000; 20:1373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16904/abstract/20\">",
"      Morey AF, McAninch JW, Tiller BK, et al. Single shot intraoperative excretory urography for the immediate evaluation of renal trauma. J Urol 1999; 161:1088.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16904/abstract/21\">",
"      Rosenstein DI, Alsikafi NF. Diagnosis and classification of urethral injuries. Urol Clin North Am 2006; 33:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16904/abstract/22\">",
"      Tinkoff G, Esposito TJ, Reed J, et al. American Association for the Surgery of Trauma Organ Injury Scale I: spleen, liver, and kidney, validation based on the National Trauma Data Bank. J Am Coll Surg 2008; 207:646.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16904/abstract/23\">",
"      Kuan JK, Wright JL, Nathens AB, et al. American Association for the Surgery of Trauma Organ Injury Scale for kidney injuries predicts nephrectomy, dialysis, and death in patients with blunt injury and nephrectomy for penetrating injuries. J Trauma 2006; 60:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16904/abstract/24\">",
"      Santucci RA, Wessells H, Bartsch G, et al. Evaluation and management of renal injuries: consensus statement of the renal trauma subcommittee. BJU Int 2004; 93:937.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 346 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-61.234.146.186-C815FD8784-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_32_16904=[""].join("\n");
var outline_f16_32_16904=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H22\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ANATOMY, PHYSIOLOGY, AND MECHANISM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PREHOSPITAL MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      PRIMARY EVALUATION AND MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Initial assessment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Approach to testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Diagnostic tests",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Urinalysis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Plain x-rays",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Ultrasound",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Retrograde urethrogram",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Retrograde cystogram",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - CT scanning",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - IV pyelography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Retrograde pyelography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      SUBSEQUENT MANAGEMENT AND CONSULTATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      PITFALLS OF MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      DEFINITIVE MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      OUTCOMES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1993320\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/346\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/346|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?29/5/29784\" title=\"figure 1\">",
"      Kidney injury grades",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/63/18425?source=related_link\">",
"      Blunt genitourinary trauma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/2/44071?source=related_link\">",
"      Evaluation and management of lower genital tract trauma in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/27/35258?source=related_link\">",
"      Evaluation of sexual abuse in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/54/3943?source=related_link\">",
"      Initial evaluation and management of abdominal gunshot wounds in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/30/12776?source=related_link\">",
"      Initial evaluation and management of abdominal stab wounds in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/11/35002?source=related_link\">",
"      Initial management of trauma in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/25/30100?source=related_link\">",
"      Management of zipper injuries",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/7/22650?source=related_link\">",
"      Pelvic trauma: Initial evaluation and management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/47/40697?source=related_link\">",
"      Placement and management of urinary bladder catheters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/4/17482?source=related_link\">",
"      Prehospital care of the adult trauma patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/53/35669?source=related_link\">",
"      Straddle injuries",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_32_16905="EP study tracings mapping slow AV nodal pathway";
var content_f16_32_16905=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F77513%7ECARD%2F58652&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F77513%7ECARD%2F58652&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 602px\">",
"   <div class=\"ttl\">",
"    Intracardiac and surface ECG recordings during electrophysiologic study showing identification of slow pathway for ablation of AV nodal reentrant tachycardia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 582px; height: 413px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Shown are three surface ECG leads (I, aVF, V1), and intracardiac recordings from the high right atrium (HRA3-4), proximal (HBE3-4,) and distal His bundle region (HBE1-2), proximal to distal coronary sinus (CS9-10, CS7-8, CS5-6, CS3-4, and CS1-2), and the right ventricular apex (RVA3-4). The patient had a history of medically refractory supraventricular arrhythmia and the diagnostic study revealed easily inducible, typical atrioventricular (AV) nodal reentrant tachycardia. The HBE catheter was maneuvered from the His position to the slow pathway region, which is typically inferior and posterior to the His bundle and just anterior to the coronary sinus ostium. This is an ideal site for slow pathway ablation and has a small atrial electrogram (A) and large ventricular electrogram (V), with no evidence of His bundle activity. The tip of the HBE catheter (HBE1-2) records such a signal, and is used for ablation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 552px\">",
"   <div class=\"ttl\">",
"    Intracardiac and surface ECG recordings during electrophysiologic study showing identification of site for ablation of AV nodal reentrant tachycardia (AVNRT)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 532px; height: 365px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Shown are three surface ECG leads (I, aVF, V1) and intracardiac recordings from the high right atrium (HRA3-4); proximal (HBE3-4) and distal His bundle region (HBE1-2), which is obtained from the mapping catheter; proximal to distal coronary sinus (CS9-10, CS7-8, CS5-6, CS3-4, and CS1-2); and the right ventricular apex (RVA3-4). During sinus rhythm, the usual atrial (A) to ventricular (V) activiation sequence is seen. Application of radiofrequency (RF) energy to the tip of the HBE catheter (HBE1-2) promptly causes an accelerated junctional rhythm (*), further evidence of a good ablation site. Note that during the accelerated junctional rhythm, there is rapid 1:1 retrograde conduction to the atria (A), evidence that the fast AV nodal pathway is intact. Following this energy application, there was no evidence of slow pathway conduction and no inducible AVNRT.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_32_16905=[""].join("\n");
var outline_f16_32_16905=null;
var title_f16_32_16906="Interstitial lung disease associated with Sjögren's syndrome: Clinical manifestations, evaluation, and diagnosis";
var content_f16_32_16906=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Interstitial lung disease associated with Sj&ouml;gren's syndrome: Clinical manifestations, evaluation, and diagnosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/32/16906/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/32/16906/contributors\">",
"     Carlos Roberto Ribeiro de Carvalho, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/32/16906/contributors\">",
"     Daniel Deheinzelin, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/32/16906/contributors\">",
"     Ronaldo A Kairalla, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/32/16906/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/32/16906/contributors\">",
"     Talmadge E King, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/32/16906/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/32/16906/contributors\">",
"     Helen Hollingsworth, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?16/32/16906/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 10, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sj&ouml;gren's syndrome (SS) is a chronic inflammatory disorder characterized by diminished lacrimal and salivary gland function and associated with lymphocytic infiltration of exocrine glands, especially the lacrimal and salivary glands. In addition to causing dry eyes (keratoconjunctivitis sicca) and dry mouth (xerostomia), SS can affect extraglandular organ systems including the skin, lung, heart, kidney, neural, and hematopoietic systems.",
"   </p>",
"   <p>",
"    Respiratory complications of SS include airway mucosal dryness (also known as xerotrachea), a variety of interstitial lung diseases (ILDs), non-Hodgkin lymphomas, pleural thickening or effusion, and, rarely, thromboembolic disease or pulmonary hypertension.",
"   </p>",
"   <p>",
"    The clinical manifestations, evaluation, and diagnosis of interstitial lung disease in SS will be reviewed here. The clinical manifestations, classification, criteria for diagnosis, and pathogenesis of Sj&ouml;gren's syndrome are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/1/11287?source=see_link\">",
"     \"Clinical manifestations of Sj&ouml;gren's syndrome: Exocrine gland disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/42/27306?source=see_link\">",
"     \"Clinical manifestations of Sj&ouml;gren's syndrome: Extraglandular disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/22/18794?source=see_link\">",
"     \"Classification and diagnosis of Sj&ouml;gren's syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/36/25162?source=see_link\">",
"     \"Pathogenesis of Sj&ouml;gren's syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H346756766\">",
"    <span class=\"h1\">",
"     NOMENCLATURE",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H87632609\">",
"    <span class=\"h2\">",
"     American-European criteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;The American-European criteria for the diagnosis of Sj&ouml;gren's syndrome (SS) combine subjective symptoms of dry eye and dry mouth with objective signs of keratoconjunctivitis sicca and xerostomia (",
"    <a class=\"graphic graphic_table graphicRef64166 \" href=\"UTD.htm?32/33/33308\">",
"     table 1",
"    </a>",
"    ). They were not developed for clinical practice and not every patient who receives a diagnosis of SS fulfills the proposed criteria. Diseases that can mimic SS and should be considered in the differential diagnosis of SS are included in the table (",
"    <a class=\"graphic graphic_table graphicRef77821 \" href=\"UTD.htm?37/39/38524\">",
"     table 2",
"    </a>",
"    ). The diagnosis of SS is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/22/18794?source=see_link&amp;anchor=H23#H23\">",
"     \"Classification and diagnosis of Sj&ouml;gren's syndrome\", section on 'Classification criteria'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H346756698\">",
"    <span class=\"h2\">",
"     Primary Sj&ouml;gren's syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary Sj&ouml;gren's syndrome (pSS) is diagnosed only when all other systemic rheumatic diseases are excluded; it predominantly affects women between 50 and 70 years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/22/18794?source=see_link&amp;anchor=H26#H26\">",
"     \"Classification and diagnosis of Sj&ouml;gren's syndrome\", section on 'Primary SS'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H346756705\">",
"    <span class=\"h2\">",
"     Secondary Sj&ouml;gren's syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Secondary Sj&ouml;gren's syndrome (sSS) refers to SS that occurs in association with another connective tissue disease, most commonly rheumatoid arthritis, but also including systemic lupus erythematosus, systemic sclerosis, mixed connective tissue disease, and inflammatory myositis [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/22/18794?source=see_link&amp;anchor=H27#H27\">",
"     \"Classification and diagnosis of Sj&ouml;gren's syndrome\", section on 'Secondary SS'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Interstitial lung disease (ILD) is the most common pulmonary abnormality in pSS [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/4-11\">",
"     4-11",
"    </a>",
"    ]. ILD appears more common among patients with pSS than in those with sSS, although it tends to be less severe than the ILD associated with sSS or other connective tissue diseases [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/6,7,12\">",
"     6,7,12",
"    </a>",
"    ]. The greater severity of ILD in sSS may be caused by the simultaneous effects of lung involvement due to SS and the associated connective tissue disorder (eg, rheumatoid arthritis, systemic lupus erythematosus) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/6\">",
"     6",
"    </a>",
"    ]. SS-associated ILD is most common in patients who have both glandular and extraglandular manifestations [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The proportion of patients with SS who develop ILD at some point is estimated to be 25 percent, although reports describe variable frequencies [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/5,7,13-15\">",
"     5,7,13-15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Among 840 patients with pSS identified by computerized chart review, ILD was noted in 104 (12 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/16\">",
"       16",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      A series of 343 patients found evidence of pulmonary involvement in 9 percent based on reported symptoms, chest radiographs, and pulmonary function tests [",
"      <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/5\">",
"       5",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      A separate series of 36 patients with pSS found ILD in 25 percent, based on clinical, laboratory, plain chest radiograph, and functional criteria [",
"      <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/7\">",
"       7",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Less commonly, ILD can be the presenting manifestation of SS. Among a cohort of patients with various diffuse ILDs, a surprisingly high prevalence of objective xerostomia (17 percent) was reported [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/17\">",
"     17",
"    </a>",
"    ]. Definite SS was diagnosed in 5.4 percent of the cohort, suggesting that undiagnosed SS may be a more common cause of ILD than previously noted [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lung disease associated with SS is more common in women and has a median age of onset of 60 years [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/18\">",
"     18",
"    </a>",
"    ]. Onset of ILD is typically 5 to 10 years after the onset of SS, although lung disease may occasionally precede the diagnosis of SS. The symptoms and signs of SS-associated ILD depend on the type and severity of lung parenchymal and lower airway involvement [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/4-8,13-15,19\">",
"     4-8,13-15,19",
"    </a>",
"    ]. In two retrospective studies (combined total of 51 patients), the most common type of pSS-associated ILD was nonspecific interstitial pneumonia (NSIP) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. Additional types of ILD identified in these series included lymphocytic interstitial pneumonia (LIP), organizing pneumonia, usual interstitial pneumonia (UIP), primary pulmonary lymphoma, and diffuse interstitial amyloidosis.",
"   </p>",
"   <p>",
"    The pattern of presenting respiratory symptoms was assessed in a series of 20 patients with pSS-associated ILD; 18 presented with at least one pulmonary symptom, such as cough (usually nonproductive), chest pain, or dyspnea [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/20,22\">",
"     20,22",
"    </a>",
"    ]. The severity of respiratory symptoms ranges from subclinical lung disease to mild cough or dyspnea to slowly progressive respiratory insufficiency, although mild dyspnea on exertion is most common [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/12,20,23\">",
"     12,20,23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with lymphocytic interstitial pneumonia associated with SS are rarely asymptomatic; cough (71 percent) and dyspnea (61 percent) are the most common symptoms, but weight loss, fevers, and pleuritic chest pain can also be present. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/25/409?source=see_link&amp;anchor=H11#H11\">",
"     \"Lymphoid interstitial pneumonia in adults\", section on 'Symptoms'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An isolated nonproductive cough without associated dyspnea may reflect xerotrachea, a condition of excessive dryness of the airway due to Sj&ouml;gren involvement of the airway epithelial glands. (See",
"    <a class=\"local\" href=\"#H327647\">",
"     'Xerotrachea'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Occasionally, patients will report Raynaud phenomenon, arthralgias, fever, or rash. The extrapulmonary symptoms of SS are described separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/42/27306?source=see_link\">",
"     \"Clinical manifestations of Sj&ouml;gren's syndrome: Extraglandular disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/1/11287?source=see_link&amp;anchor=H2#H2\">",
"     \"Clinical manifestations of Sj&ouml;gren's syndrome: Exocrine gland disease\", section on 'Exocrine gland involvement'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Bibasilar crackles are noted on physical examination in approximately 60 percent and a normal chest examination in 28 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/16,21,24\">",
"     16,21,24",
"    </a>",
"    ]. Cutaneous vasculitis occurs in approximately 10 percent of patients with SS and can present with urticarial lesions, purpura, or punctate erosions. The extrapulmonary signs of SS and other ILDs are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/1/11287?source=see_link&amp;anchor=H2#H2\">",
"     \"Clinical manifestations of Sj&ouml;gren's syndrome: Exocrine gland disease\", section on 'Exocrine gland involvement'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/42/27306?source=see_link&amp;anchor=H2#H2\">",
"     \"Clinical manifestations of Sj&ouml;gren's syndrome: Extraglandular disease\", section on 'Extraglandular organ involvement'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/20/22856?source=see_link&amp;anchor=H17#H17\">",
"     \"Approach to the adult with interstitial lung disease: Clinical evaluation\", section on 'Extrapulmonary findings of systemic disease'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H327600\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of dyspnea and cough in SS includes xerotrachea, pulmonary vascular disease, other ILDs that may present with sicca symptoms or salivary gland involvement (eg, sarcoidosis, IgG4-related systemic disease), and ILDs related to the underlying connective tissue disease in patients with sSS (eg, rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis (scleroderma), inflammatory muscle disease). The characteristics of ILD associated with these connective tissue diseases and the differential diagnosis of ILD in general are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/31/17912?source=see_link\">",
"     \"Interstitial lung disease in rheumatoid arthritis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/60/11210?source=see_link\">",
"     \"Pulmonary manifestations of systemic lupus erythematosus in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/60/11210?source=see_link&amp;anchor=H12#H12\">",
"     \"Pulmonary manifestations of systemic lupus erythematosus in adults\", section on 'Interstitial lung disease'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/45/26329?source=see_link&amp;anchor=H3#H3\">",
"     \"Clinical manifestations of systemic sclerosis (scleroderma) lung disease\", section on 'Interstitial lung disease'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/7/24697?source=see_link\">",
"     \"Interstitial lung disease in dermatomyositis and polymyositis: Clinical manifestations and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/18/16681?source=see_link&amp;anchor=H2#H2\">",
"     \"Approach to the adult with interstitial lung disease: Diagnostic testing\", section on 'Differential diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H327647\">",
"    <span class=\"h2\">",
"     Xerotrachea",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among patients with SS, involvement of the tracheobronchial epithelial glands can lead to excessive dryness of the airway, which usually presents with a nonproductive cough. Pulmonary function tests and radiographic imaging are normal. Examination by flexible bronchoscopy reveals a dry, erythematous mucosa [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H327669\">",
"    <span class=\"h2\">",
"     Pulmonary vascular disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulmonary vascular disease (eg, thromboembolic disease, pulmonary arterial hypertension) should be considered in the differential of SS complicated by dyspnea.",
"   </p>",
"   <p>",
"    An increased risk of thromboembolic disease has been described in patients with SS [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/26\">",
"     26",
"    </a>",
"    ]. Thromboembolism should be suspected in patients with an acute onset of dyspnea, particularly when the chest radiograph does not suggest ILD. The evaluation and diagnosis of suspected pulmonary embolism is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/57/6042?source=see_link\">",
"     \"Diagnosis of acute pulmonary embolism\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Pulmonary arterial hypertension (PAH) should be considered in a patient with more gradual onset of dyspnea when the degree of dyspnea is not well-explained by the extent of ILD on high resolution computed tomography (HRCT). PAH has rarely been described in the setting of Sj&ouml;gren-associated ILD, typically in patients with Raynaud phenomenon and cutaneous vasculitis [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/27\">",
"     27",
"    </a>",
"    ]. In this review of 28 patients, antinuclear,",
"    <span class=\"nowrap\">",
"     anti-Ro/SSA,",
"    </span>",
"    and anti-ribonucleoprotein (RNP) autoantibodies, as well as positive rheumatoid factor and hypergammaglobulinemia, were often present. The evaluation and diagnosis of PAH is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/24/35210?source=see_link\">",
"     \"Treatment of pulmonary hypertension in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H327676\">",
"    <span class=\"h2\">",
"     Sj&ouml;gren's syndrome and sarcoidosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sarcoidosis can present with lacrimal and salivary gland involvement, as well as diffuse parenchymal lung disease. In addition, sarcoidosis can occur concomitantly with SS. In one patient with SS, for example, lung biopsy revealed a chronic noncaseating granulomatous inflammatory reaction with moderate lymphocytic infiltration of the surrounding alveoli, a finding that led to the concurrent diagnosis of sarcoidosis [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/28\">",
"     28",
"    </a>",
"    ]. A literature review of histopathologic changes in the exocrine glands of 53 patients with sarcoidosis noted coexistence of sarcoidosis and SS in 28 cases; in the remaining 25 patients, sarcoidosis mimicked SS [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/29\">",
"     29",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/25/21914?source=see_link&amp;anchor=H37#H37\">",
"     \"Clinical manifestations and diagnosis of sarcoidosis\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Potential explanations for the simultaneous occurrence of both disorders include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The two diseases share a common immunologic abnormality",
"     </li>",
"     <li>",
"      The derangement caused by one disorder may result in the other",
"     </li>",
"     <li>",
"      The finding is coincidental",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Possible support for the first hypothesis comes from a study of lung biopsy specimens from 10 patients with SS [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/30\">",
"     30",
"    </a>",
"    ]. There were significant elevations in CD4 positive lymphocytes in the bronchial mucosa, an abnormality that is also described in sarcoidosis. In general, sarcoidosis and SS are differentiated by the preponderance of noncaseating granulomata found on biopsy specimens from patients with sarcoidosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/14/6376?source=see_link\">",
"     \"Pathogenesis of sarcoidosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/25/21914?source=see_link&amp;anchor=H36#H36\">",
"     \"Clinical manifestations and diagnosis of sarcoidosis\", section on 'Histopathology'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H327683\">",
"    <span class=\"h2\">",
"     IgG4-related systemic disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;IgG4-related systemic disease, also known as IgG4-related sclerosing disease or hyper-IgG4 disease, is felt to be distinct from SS. Patients with IgG4-related systemic disease experience relatively mild xerophthalmia and xerostomia, although marked lacrimal and salivary gland enlargement may occur. Lung involvement in IgG4-related systemic disease is estimated to occur in 10 percent and pleural involvement in 5 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/31\">",
"     31",
"    </a>",
"    ]. A variety of chest computed tomography (CT) presentations have been described, including patchy ground glass, nodular and consolidative opacities, and also honeycombing [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/32\">",
"     32",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/55/13178?source=see_link\">",
"     \"Overview of IgG4-related disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    IgG4-related systemic disease is characterized by increased serum levels of IgG4, IgG4-positive plasmacytic infiltration and sclerosis of a wide variety of exocrine glands, most commonly the pancreas (",
"    <a class=\"graphic graphic_table graphicRef81268 \" href=\"UTD.htm?35/43/36539\">",
"     table 3",
"    </a>",
"    ). The diagnosis of IgG4-related systemic disease is based on the clinical features, a serum concentration of IgG4 &ge;2 times the upper limit of normal (140",
"    <span class=\"nowrap\">",
"     mg/dL)",
"    </span>",
"    and the presence of IgG4 positive cells on histopathology. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/14/40168?source=see_link&amp;anchor=H7#H7\">",
"     \"Autoimmune pancreatitis\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9740885\">",
"    <span class=\"h2\">",
"     Other causes of diffuse parenchymal lung disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other causes of diffuse lung disease that are not associated with SS, but are generally in the differential of ILD include hypersensitivity pneumonia, eosinophilic pneumonia, infection, lymphangitic tumor, and hemorrhage. The evaluation of these entities is discussed in the appropriate topic reviews. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/20/22856?source=see_link\">",
"     \"Approach to the adult with interstitial lung disease: Clinical evaluation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H346757511\">",
"    <span class=\"h1\">",
"     EVALUATION AND DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnostic approach to suspected ILD in patients with SS follows the general approach to interstitial lung disease. Because of the high frequency of lung involvement in SS and the potential for sarcoidosis to mimic SS, we typically obtain a chest radiograph as part of the initial evaluation of a patient with SS. If ILD is suspected on the basis of cough, dyspnea, audible crackles, or an abnormal chest radiograph, we obtain complete pulmonary function tests and a high resolution computed tomography scan. Further evaluation is based on the results of these tests. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/20/22856?source=see_link\">",
"     \"Approach to the adult with interstitial lung disease: Clinical evaluation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/18/16681?source=see_link\">",
"     \"Approach to the adult with interstitial lung disease: Diagnostic testing\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Laboratory",
"    </span>",
"    &nbsp;&mdash;&nbsp;When ILD is suspected in a patient with SS, we usually confirm the original diagnosis of SS by reviewing or obtaining serologic studies such as the antinuclear antibody,",
"    <span class=\"nowrap\">",
"     anti-Ro/SSA",
"    </span>",
"    and",
"    <span class=\"nowrap\">",
"     anti-La/SSB",
"    </span>",
"    antibodies, rheumatoid factor, and serum protein electrophoresis. The laboratory evaluation and diagnosis of SS are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/22/18794?source=see_link&amp;anchor=H10#H10\">",
"     \"Classification and diagnosis of Sj&ouml;gren's syndrome\", section on 'Diagnostic tests'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/23/8568?source=see_link&amp;anchor=H11717369#H11717369\">",
"     \"The anti-Ro/SSA and anti-La/SSB antigen-antibody systems\", section on 'Sj&ouml;gren&rsquo;s syndrome'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/42/27306?source=see_link&amp;anchor=H3#H3\">",
"     \"Clinical manifestations of Sj&ouml;gren's syndrome: Extraglandular disease\", section on 'Serologic findings'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    No serologic marker has been identified that predicts the development of ILD in patients with pSS or sSS, and most studies conclude that patients with interstitial involvement have a similar immunologic profile compared to those without lung disease [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]. In a series of 14 patients with pSS-associated ILD who underwent lung biopsy, antinuclear antibodies (ANA) were noted in six,",
"    <span class=\"nowrap\">",
"     anti-Ro/SS-A",
"    </span>",
"    antibody in eight, and",
"    <span class=\"nowrap\">",
"     anti-La/SS-B",
"    </span>",
"    antibody in two [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/16\">",
"     16",
"    </a>",
"    ]. Similar findings were noted in a series of 13 patients with ILD and SS (diagnosed by a positive minor salivary gland biopsy): ANA and",
"    <span class=\"nowrap\">",
"     anti-Ro/SS-A",
"    </span>",
"    antibodies were positive in eight; rheumatoid factor (RF) in three; and",
"    <span class=\"nowrap\">",
"     anti-La/SS-B",
"    </span>",
"    antibody in two [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Limited data are available to assess whether specific antibodies correlate with disease severity. A series of 30 patients noted that",
"    <span class=\"nowrap\">",
"     anti-Ro/SS-A",
"    </span>",
"    antibody positivity correlated with a significantly lower diffusing capacity than",
"    <span class=\"nowrap\">",
"     anti-Ro/SS-A",
"    </span>",
"    antibody negativity [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If IgG4-related systemic disease is suspected due to marked lacrimal and salivary gland enlargement, immunoglobulin subclass levels are obtained looking for an elevated level of IgG4. (See",
"    <a class=\"local\" href=\"#H327683\">",
"     'IgG4-related systemic disease'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/14/40168?source=see_link&amp;anchor=H11#H11\">",
"     \"Autoimmune pancreatitis\", section on 'Serologic testing for IgG4'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Chest imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;A chest radiograph is usually obtained as part of the initial evaluation of patients with SS due to the frequency of lung involvement and as sarcoidosis is included in the differential diagnosis. The chest radiograph is repeated if respiratory symptoms develop or change.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17659888\">",
"    <span class=\"h3\">",
"     Chest radiograph",
"    </span>",
"    &nbsp;&mdash;&nbsp;The chest radiograph in patients with SS-associated ILD typically shows a fine reticular or nodular pattern with basilar prominence, but may be normal. Retrospective series of patients with either pSS or sSS have noted abnormalities on chest radiograph in 10 to 20 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/5,36\">",
"     5,36",
"    </a>",
"    ]. Based on small case series, the rate of radiographic abnormalities may be higher in patients with pSS than sSS [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/22\">",
"     22",
"    </a>",
"    ]. The most common findings are reticular or ground glass opacities, although cysts and pleural abnormalities have been described [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/5,37\">",
"     5,37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17659895\">",
"    <span class=\"h3\">",
"     High resolution computed tomography",
"    </span>",
"    &nbsp;&mdash;&nbsp;High resolution computed tomography (HRCT) is obtained in patients with SS if respiratory symptoms develop or if the chest radiograph or pulmonary function tests are abnormal. High resolution computed tomography (HRCT) is more sensitive than the chest radiograph for interstitial lung disease [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/23,38,39\">",
"     23,38,39",
"    </a>",
"    ]. In a series of 37 patients with SS and normal chest radiographs, 25 (64 percent) had abnormalities on HRCT [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/24\">",
"     24",
"    </a>",
"    ]. A separate study found abnormalities suggestive of interstitial lung disease on CT in 34 percent of patients with pSS, while the chest radiograph was abnormal in only 14 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/39\">",
"     39",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/29/16858?source=see_link\">",
"     \"High resolution computed tomography of the lungs\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A variety of HRCT patterns have been reported in ILD associated with SS [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/16,39-41\">",
"     16,39-41",
"    </a>",
"    ]. As an example, in a series of 60 patients with pSS-associated ILD, HRCT abnormalities included ground-glass attenuation (92 percent), subpleural small nodules (78 percent), non-septal linear opacities (75 percent), interlobular septal thickening (55 percent), bronchiectasis (38 percent), and cysts (30 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/40\">",
"     40",
"    </a>",
"    ]. Bronchial wall thickening and pleural irregularities are less frequently noted [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/23\">",
"     23",
"    </a>",
"    ]. The frequency of each pattern depends on the characteristics of the population studied. As an example, among four studies of symptomatic patients with ILD, the frequency of nonspecific interstitial pneumonia patterns ranged from 20 to 60 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/20,39,42,43\">",
"     20,39,42,43",
"    </a>",
"    ]. In two studies of asymptomatic patients, eight percent had HRCT findings consistent with pulmonary fibrosis (honeycombing) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/23,39\">",
"     23,39",
"    </a>",
"    ]. In a separate series, honeycombing was almost four times more common in sSS as compared with pSS, likely due to the presence of usual interstitial pneumonia in patients with rheumatoid arthritis.",
"   </p>",
"   <p>",
"    HRCT findings in lymphocytic interstitial pneumonia (LIP) include thin-walled cysts, ground-glass attenuation, centrilobular and subpleural nodules, septal thickening, reticular opacities, and",
"    <span class=\"nowrap\">",
"     bronchial/bronchiolar",
"    </span>",
"    thickening (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef65519 \" href=\"UTD.htm?0/30/481\">",
"     image 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/23,42,44\">",
"     23,42,44",
"    </a>",
"    ]. Cyst formation is more common in patients with lymphocytic interstitial pneumonia and those with",
"    <span class=\"nowrap\">",
"     anti-SSB/La",
"    </span>",
"    antibodies [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/18\">",
"     18",
"    </a>",
"    ].",
"    <span class=\"nowrap\">",
"     Bronchial/bronchiolar",
"    </span>",
"    thickening may be due to associated follicular bronchiolitis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/25/409?source=see_link&amp;anchor=H14#H14\">",
"     \"Lymphoid interstitial pneumonia in adults\", section on 'Chest imaging'",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H14\">",
"     'Follicular bronchiolitis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Pulmonary nodular lymphoid hyperplasia typically presents with a solitary mass or nodule, but can present with multiple nodules or as an area of parenchymal consolidation with an air bronchogram [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/19,45\">",
"     19,45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the rare patients with SS-associated amyloidosis, HRCT findings include diffuse nodules, focal consolidation, and diffuse septal thickening [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Pulmonary function tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulmonary function tests (PFTs) are obtained to evaluate respiratory symptoms, crackles on chest examination, or an abnormal chest radiograph. The main role of PFTs is to confirm the presence of abnormalities consistent with ILD and to assess the severity of respiratory impairment.",
"   </p>",
"   <p>",
"    Patients with SS and diffuse parenchymal opacities on chest radiographs typically have a restrictive pattern on PFTs with a low diffusing capacity [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/6,10,14,20,47-49\">",
"     6,10,14,20,47-49",
"    </a>",
"    ]. In one study of 20 patients with pSS, significant reductions in FEV",
"    <sub>",
"     1",
"    </sub>",
"    , vital capacity, and diffusing capacity (transfer factor for carbon monoxide or DLCO) were noted in 14, 12, and 10 patients, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/12\">",
"     12",
"    </a>",
"    ]. The combination of a restrictive defect and a low DLCO appears to be more common in pSS than in sSS [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/6,10\">",
"     6,10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An isolated obstructive pattern is unusual in pSS; this pattern is more common in sSS or with rheumatoid arthritis alone [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/6,10\">",
"     6,10",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/21/26969?source=see_link\">",
"     \"Overview of lung disease associated with rheumatoid arthritis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/31/17912?source=see_link\">",
"     \"Interstitial lung disease in rheumatoid arthritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Evidence of small airway airflow obstruction is common in nonsmoking patients with pSS [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/23,44\">",
"     23,44",
"    </a>",
"    ]. This pattern is frequently associated with asymptomatic disease [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H346757694\">",
"    <span class=\"h2\">",
"     Minor salivary gland biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Occasionally, ILD is the presenting manifestation of pSS and the presence of sicca symptoms is elicited during the evaluation of ILD [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/35\">",
"     35",
"    </a>",
"    ]. In these patients, a minor salivary gland biopsy may lead to a more precise diagnosis of the underlying connective tissue disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/22/18794?source=see_link&amp;anchor=H20#H20\">",
"     \"Classification and diagnosis of Sj&ouml;gren's syndrome\", section on 'Salivary gland biopsy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Bronchoalveolar lavage",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bronchoalveolar lavage (BAL) cell count patterns in SS are nonspecific, so the main role of BAL in a patient who is suspected of having SS-associated ILD is to exclude other causes of diffuse parenchymal lung disease, such as eosinophilic pneumonia, infection, lymphangitic tumor, and hemorrhage. Thus, BAL is usually performed in patients with SS and ILD when respiratory symptoms have an acute onset or are accompanied by a fever, hemoptysis, or peripheral eosinophilia. BAL results would not be sufficient to differentiate sarcoidosis from SS-associated ILD. The technique of BAL and the role of BAL in the diagnosis of interstitial lung disease are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/41/25239?source=see_link\">",
"     \"Basic principles and technique of bronchoalveolar lavage\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/36/16968?source=see_link\">",
"     \"Role of bronchoalveolar lavage in diagnosis of interstitial lung disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Increased numbers of BAL lymphocytes or neutrophils are common among patients with pSS. However, the data are conflicting about whether the degree of lymphocytosis or neutrophilia predicts the presence or severity of ILD. Among 13 patients with symptomatic pSS-associated ILD, BAL revealed either lymphocytosis or an increased number of polymorphonuclear cells [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a study of 23 patients with pSS, those patients whose BAL contained greater than 15 percent lymphocytes, were more likely to have pulmonary symptoms (cough and dyspnea), radiographic evidence of interstitial lung disease, and decreased pulmonary function than those whose BAL had less than 15 percent lymphocytes [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    On the other hand, elevated numbers of lymphocytes or neutrophils can be seen in the BAL of patients without clinical or radiographic evidence of pulmonary disease [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/28\">",
"     28",
"    </a>",
"    ]. Among 29 patients with pSS who did not have pulmonary symptoms or chest radiograph abnormalities, elevated BAL lymphocytes or neutrophils were noted in 55 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/28\">",
"     28",
"    </a>",
"    ]. It is unknown whether patients with subclinical disease based on BAL results will develop symptomatic pulmonary disease.",
"   </p>",
"   <p>",
"    The prognostic value of BAL cell counts in SS-associated ILD is also unclear. Among 18 patients with pSS and an initial lymphocytic or mixed",
"    <span class=\"nowrap\">",
"     lymphocytic/neutrophilic",
"    </span>",
"    BAL, chest radiographs and pulmonary function were virtually unchanged over two years [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/43\">",
"     43",
"    </a>",
"    ]. Of 14 patients with an initial lymphocytic BAL (&gt;15 percent lymphocytes), the BAL differential normalized in six. BAL neutrophilia was associated with a greater rate of reduction in the diffusing capacity of carbon monoxide (DLCO), than BAL lymphocytosis. In contrast, a longer study (12 years) found that only those patients with greater than 15 percent lymphocytosis in their BAL died [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Lung biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lung biopsy is not always necessary when evaluating patients with SS and radiographic",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    physiologic evidence of ILD. The usual indications for lung biopsy are a suspicion of malignancy or a combination of increasing respiratory symptoms, deteriorating pulmonary function studies, atypical HRCT pattern, and worsening radiographic abnormalities. Circumscribed or nodular areas of consolidation that are persistent and not attributable to infection generally require histopathologic evaluation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/26/424?source=see_link&amp;anchor=H2#H2\">",
"     \"Role of lung biopsy in the diagnosis of interstitial lung disease\", section on 'Indications'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Depending on the location of the abnormality and local expertise, transbronchial, video-assisted thoracoscopic, or open lung biopsy may be performed. Transbronchial lung biopsy is helpful in the positive diagnosis of sarcoidosis or lymphangitic carcinomatosis, whereas a larger biopsy from video-assisted thoracoscopic or open thoracotomy is needed to differentiate the various types of ILD. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/26/424?source=see_link&amp;anchor=H3#H3\">",
"     \"Role of lung biopsy in the diagnosis of interstitial lung disease\", section on 'Types of lung biopsy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Histopathology",
"    </span>",
"    &nbsp;&mdash;&nbsp;A wide spectrum of histopathologic findings have been reported in patients with SS, most commonly those that mirror the main types of idiopathic interstitial pneumonia (eg, nonspecific interstitial pneumonia, lymphocytic interstitial pneumonia, end-stage fibrosis with honeycombing, organizing pneumonia) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/16,20-22,35,51\">",
"     16,20-22,35,51",
"    </a>",
"    ]. Lymphocytic infiltration is a characteristic of SS manifestations throughout the body and several patterns of lymphocytic lung involvement have been described: lymphocytic interstitial pneumonia, follicular bronchiolitis, nodular lymphoid hyperplasia, and lymphoma. It is not clear whether there is an evolution from one lymphocytic pattern to another. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/23/4474?source=see_link\">",
"     \"Idiopathic interstitial pneumonias: Clinical manifestations and pathology\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Nonspecific interstitial pneumonia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nonspecific interstitial pneumonia (NSIP) is the most common form of lung inflammation found in patients with SS [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. The NSIP pattern is also recognized as the most common pattern in several other connective tissue diseases, including systemic sclerosis,",
"    <span class=\"nowrap\">",
"     polymyositis/dermatomyositis,",
"    </span>",
"    rheumatoid arthritis and systemic lupus erythematosus. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/25/42393?source=see_link\">",
"     \"Nonspecific interstitial pneumonia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Within the category of NSIP, three subsets have been described: a cellular pattern with a greater degree of interstitial inflammation, a more fibrotic pattern, and a mixed pattern (",
"    <a class=\"graphic graphic_table graphicRef81034 \" href=\"UTD.htm?19/8/19596\">",
"     table 4",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef75438 \" href=\"UTD.htm?27/22/28008\">",
"     picture 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef58583 \" href=\"UTD.htm?43/22/44392\">",
"     picture 2",
"    </a>",
"    ). The significance of these subsets is not entirely clear, although the more fibrotic pattern appears to have a worse prognosis. In a series of 20 patients with NSIP associated with primary SS, the fibrotic pattern of NSIP was noted in 19 and the cellular pattern in one [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/20\">",
"     20",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/25/42393?source=see_link&amp;anchor=H8#H8\">",
"     \"Nonspecific interstitial pneumonia\", section on 'Pathology'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18332038\">",
"    <span class=\"h3\">",
"     Lymphocytic interstitial pneumonia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lymphocytic interstitial pneumonia (LIP) is characterized by an extensive proliferation of lymphoid cells (T and B) and varying numbers of plasma cells along the alveolar septae, often associated with follicular bronchiolitis (",
"    <a class=\"graphic graphic_table graphicRef69805 \" href=\"UTD.htm?22/25/22939\">",
"     table 5",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef53820 \" href=\"UTD.htm?12/20/12613\">",
"     picture 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef63982 \" href=\"UTD.htm?12/46/13032\">",
"     picture 4",
"    </a>",
"    ). Germinal centers and multinucleated giant cells with occasional noncaseating granulomas are also described (",
"    <a class=\"graphic graphic_picture graphicRef52227 \" href=\"UTD.htm?6/20/6468\">",
"     picture 5",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef63982 \" href=\"UTD.htm?12/46/13032\">",
"     picture 4",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef75674 \" href=\"UTD.htm?34/37/35415\">",
"     picture 6",
"    </a>",
"    ). With advanced disease, fibrotic changes with cyst formation or honeycombing are seen. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/25/409?source=see_link&amp;anchor=H9#H9\">",
"     \"Lymphoid interstitial pneumonia in adults\", section on 'Pathologic findings'",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H14\">",
"     'Follicular bronchiolitis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14750069\">",
"    <span class=\"h3\">",
"     Usual interstitial pneumonia",
"    </span>",
"    &nbsp;&mdash;&nbsp;The histologic hallmark and chief diagnostic criterion of usual interstitial pneumonia (UIP) is a heterogeneous appearance with alternating areas of normal lung, interstitial inflammation, fibroblast foci, and honeycomb change. The histopathologic pattern of UIP is more commonly seen in patients with sSS associated with rheumatoid arthritis or systemic sclerosis, than in pSS. Among 42 patients with pSS and interstitial lung disease, none had UIP on biopsy, although UIP had been suspected based on high resolution computed tomography (HRCT) in four [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/20\">",
"     20",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/23/4474?source=see_link&amp;anchor=H5#H5\">",
"     \"Idiopathic interstitial pneumonias: Clinical manifestations and pathology\", section on 'Pathology'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14749613\">",
"    <span class=\"h3\">",
"     Organizing pneumonia",
"    </span>",
"    &nbsp;&mdash;&nbsp;The characteristic histopathologic lesions of organizing pneumonia include excessive proliferation of granulation tissue within small airways (proliferative bronchiolitis) and alveolar ducts, associated with chronic inflammation in the surrounding alveoli. Foci of organizing pneumonia can be seen in association with NSIP. Organizing pneumonia is an uncommon complication of pSS [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/21,52,53\">",
"     21,52,53",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Nonspecific interstitial pneumonia'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/60/19402?source=see_link&amp;anchor=H2#H2\">",
"     \"Cryptogenic organizing pneumonia\", section on 'Pathology'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Follicular bronchiolitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Follicular bronchiolitis is characterized by lymphoid hyperplasia of mucosa-associated lymphoid tissue (MALT), also known as bronchus-associated lymphoid tissue (BALT) when it refers to peribronchial tissue. Hyperplastic lymphoid follicles with reactive germinal centers are distributed along the bronchioles and can cause compression of the airway lumen (",
"    <a class=\"graphic graphic_picture graphicRef63982 \" href=\"UTD.htm?12/46/13032\">",
"     picture 4",
"    </a>",
"    ). The lymphoid proliferation is generally limited to the peribronchiolar area, but may extend into the surrounding alveolar septa [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/30,44\">",
"     30,44",
"    </a>",
"    ]. In SS, follicular bronchiolitis is seen alone and in association with NSIP or LIP [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/16\">",
"     16",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/43/24247?source=see_link&amp;anchor=H8#H8\">",
"     \"Bronchiolitis in adults\", section on 'Follicular bronchiolitis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Nodular lymphoid hyperplasia (pseudolymphoma)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nodular lymphoid hyperplasia (also known as follicular lymphoid hyperplasia or the now outdated term &ldquo;pseudolymphoma&rdquo;) is characterized by mixed infiltrates of mature lymphocytes and plasma cells with numerous germinal centers (",
"    <a class=\"graphic graphic_picture graphicRef55114 graphicRef68369 graphicRef82569 \" href=\"UTD.htm?35/53/36698\">",
"     picture 7A-C",
"    </a>",
"    ). Nodular lymphoid hyperplasia has been described in the lung, salivary glands, skin, and kidney of patients with SS and is more common in patients with pSS than other connective tissue diseases [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/30,45,54-56\">",
"     30,45,54-56",
"    </a>",
"    ]. It may regress, remain stable, or progress to frank lymphoma [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Nodular lymphoid hyperplasia has certain key features that are used to differentiate it from marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT), including a well-circumscribed lesion, minimal lymphangitic spread, presence of polyclonal lymphocytes, absence of intranuclear inclusions, and absence of immunoglobulin heavy chain rearrangements [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/30\">",
"     30",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/9/19610?source=see_link\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of extranodal (MALT) and nodal marginal zone lymphomas\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3926787\">",
"    <span class=\"h3\">",
"     Lymphoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;The lung malignancies most frequently associated with SS are the non-Hodgkin lymphomas, and among these, the most common is pulmonary marginal zone lymphoma (MZL, also known as mucosa-associated lymphoid tissue [MALT] lymphoma or bronchial-associated lymphoid tissue [BALT] lymphoma) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/20\">",
"     20",
"    </a>",
"    ]. Involvement of the lung by lymphoma occurs in approximately 20 percent of patients with SS-associated lymphoma [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/57\">",
"     57",
"    </a>",
"    ]. A spectrum of low- to high-grade lymphomas is reported [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/57\">",
"     57",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/61/27610?source=see_link\">",
"     \"Clinical presentation and diagnosis of non-Hodgkin lymphoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/9/19610?source=see_link&amp;anchor=H2#H2\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of extranodal (MALT) and nodal marginal zone lymphomas\", section on 'Extranodal (MALT) MZL'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H346757020\">",
"    <span class=\"h3\">",
"     Pulmonary nodular amyloidosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulmonary nodular amyloidosis is occasionally described in association with SS (usually pSS) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/20,46,58,59\">",
"     20,46,58,59",
"    </a>",
"    ]. Nodules containing lymphocytes, plasma cells and amyloid deposits (identified by Congo red staining showing green birefringence under polarized light) are reported, sometimes adjacent to or in the wall of lung cysts [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/58\">",
"     58",
"    </a>",
"    ]. In a case report and review, deposition of AL (lambda or kappa light chain) or AA amyloid occurred in the absence of systemic amyloidosis [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/46\">",
"     46",
"    </a>",
"    ]. Most cases of amyloid associated with SS are related to the nodular pattern of amyloidosis [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/46\">",
"     46",
"    </a>",
"    ]. Association with lymphoproliferative disease, such as mucosa-associated lymphoid tissue (MALT) lymphoma, has also been described [",
"    <a class=\"abstract\" href=\"UTD.htm?16/32/16906/abstract/58,60\">",
"     58,60",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/31/1530?source=see_link&amp;anchor=H17#H17\">",
"     \"An overview of amyloidosis\", section on 'Pulmonary disease'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/15/7418?source=see_link&amp;anchor=H1665772#H1665772\">",
"     \"Clinical presentation, laboratory manifestations, and diagnosis of immunoglobulin light chain (AL) amyloidosis (primary amyloidosis)\", section on 'Tissue biopsy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Sj&ouml;gren's syndrome (SS) is characterized by a particular form of dry eyes (keratoconjunctivitis sicca) and dry mouth (xerostomia). SS can exist as a primary disorder or as a condition in association with another well-defined autoimmune process such as rheumatoid arthritis, systemic lupus erythematosus (SLE), scleroderma, or inflammatory myositis. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H346756766\">",
"       'Nomenclature'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The proportion of patients with SS who develop ILD at some point is estimated to be 25 percent. Interstitial lung disease (ILD) is more common among patients with primary SS than in those with secondary SS, although it tends to be more severe in secondary SS. &nbsp;(See",
"      <a class=\"local\" href=\"#H4\">",
"       'Epidemiology'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/22/18794?source=see_link\">",
"       \"Classification and diagnosis of Sj&ouml;gren's syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The differential diagnosis of dyspnea and cough in SS includes xerotrachea, pulmonary vascular disease, other ILDs that may present with sicca symptoms or salivary gland involvement (eg, sarcoidosis, IgG4-related systemic disease), and ILDs related to the underlying connective tissue disease in patients with sSS (eg, rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis (scleroderma), inflammatory muscle disease). (See",
"      <a class=\"local\" href=\"#H327600\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We typically obtain a chest radiograph as part of the initial evaluation of a patient with SS. If ILD is suspected on the basis of cough, dyspnea, audible crackles, or an abnormal chest radiograph, we obtain pulmonary function tests and a high resolution computed tomography scan. (See",
"      <a class=\"local\" href=\"#H346757511\">",
"       'Evaluation and diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      If not already performed, we obtain laboratory tests to confirm the diagnosis of SS, including an antinuclear antibody,",
"      <span class=\"nowrap\">",
"       anti-Ro/SSA",
"      </span>",
"      and",
"      <span class=\"nowrap\">",
"       anti-La/SSB",
"      </span>",
"      antibodies, rheumatoid factor, and serum protein electrophoresis. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Laboratory'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with sicca symptoms and evidence of ILD, but without a firm diagnosis of SS, we typically obtain a minor salivary gland biopsy in addition to the laboratory testing noted above. (See",
"      <a class=\"local\" href=\"#H346757694\">",
"       'Minor salivary gland biopsy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      High resolution computed tomography (HRCT) findings include bronchial wall thickening, bronchiectasis, centrilobular nodules, irregular interlobular thickening, ground-glass attenuation, subpleural honeycombing, thin-walled cysts, and branching linear hyperattenuating areas. Ground glass attenuation is most common. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Chest imaging'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Bronchoalveolar lavage (BAL) most commonly shows a predominance of lymphocytes in patients with SS-associated ILD, but may occasionally show a predominance of neutrophils. The main role of bronchoalveolar lavage (BAL) in a patient with SS and radiographic evidence of ILD is to exclude other causes of interstitial opacities, such as eosinophilic pneumonia, infection, lymphangitic tumor, and hemorrhage. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Bronchoalveolar lavage'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Lung biopsy is generally not necessary when evaluating patients with SS and radiographic",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      physiologic evidence of ILD, when the clinical and physiologic impairments are mild and stable. The usual indications for lung biopsy are a suspicion of malignancy (especially if associated with a nodular pattern or masses) or a combination of increasing respiratory symptoms, deteriorating pulmonary function studies, and worsening radiographic abnormalities. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Lung biopsy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Common histopathologic patterns include nonspecific interstitial pneumonia (NSIP), usual interstitial pneumonia (UIP), organizing pneumonia, and lymphocytic interstitial pneumonia (LIP). Follicular bronchiolitis nodular lymphoid hyperplasia, lymphoma, and pulmonary nodular amyloidosis are seen less commonly. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Histopathology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The management of the ILDs associated with SS is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/37/25174?source=see_link&amp;anchor=H17660654#H17660654\">",
"       \"Interstitial lung disease associated with Sj&ouml;gren's syndrome: Management and prognosis\", section on 'Management'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/1\">",
"      Oxholm P. Primary Sj&ouml;gren's syndrome--clinical and laboratory markers of disease activity. Semin Arthritis Rheum 1992; 22:114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/2\">",
"      Fox RI. Sj&ouml;gren's syndrome. Lancet 2005; 366:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/3\">",
"      Prause JU, Manthorpe R, Oxholm P, Schi&oslash;dt M. Definition and criteria for Sj&ouml;gren's syndrome used by the contributors to the First International Seminar on Sj&ouml;gren's syndrome--1986. Scand J Rheumatol Suppl 1986; 61:17.",
"     </a>",
"    </li>",
"    <li>",
"     Freemer MM, King TE Jr. Connective tissue disease. In: Interstitial Lung Disease, King TE Jr, Schwarz MI (Eds), BC Decker, Hamilton, Ontario 2003. p.535.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/5\">",
"      Strimlan, CV, Rosenow, EC, Divertie, MB, et al. Pulmonary manifestations of Sj&ouml;gren's syndrome. Chest 1976; 70:354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/6\">",
"      Vitali C, Tavoni A, Viegi G, et al. Lung involvement in Sj&ouml;gren's syndrome: a comparison between patients with primary and with secondary syndrome. Ann Rheum Dis 1985; 44:455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/7\">",
"      Constantopoulos SH, Papadimitriou CS, Moutsopoulos HM. Respiratory manifestations in primary Sj&ouml;gren's syndrome. A clinical, functional, and histologic study. Chest 1985; 88:226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/8\">",
"      Cain HC, Noble PW, Matthay RA. Pulmonary manifestations of Sj&ouml;gren's syndrome. Clin Chest Med 1998; 19:687.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/9\">",
"      Hunninghake GW, Fauci AS. Pulmonary involvement in the collagen vascular diseases. Am Rev Respir Dis 1979; 119:471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/10\">",
"      Papathanasiou MP, Constantopoulos SH, Tsampoulas C, et al. Reappraisal of respiratory abnormalities in primary and secondary Sj&ouml;gren's syndrome. A controlled study. Chest 1986; 90:370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/11\">",
"      Lynch, JP III, Hunninghake, GW. Pulmonary complications of collagen vascular disease. Annu Rev Med 1992; 43:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/12\">",
"      Vitali C, Viegi G, Tassoni S, et al. Lung function abnormalities in different connective tissue diseases. Clin Rheumatol 1986; 5:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/13\">",
"      Newball HH, Brahim SA. Chronic obstructive airway disease in patients with Sj&ouml;gren's syndrome. Am Rev Respir Dis 1977; 115:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/14\">",
"      Fairfax AJ, Haslam PL, Pavia D, et al. Pulmonary disorders associated with Sj&ouml;gren's syndrome. Q J Med 1981; 50:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/15\">",
"      Segal I, Fink G, Machtey I, et al. Pulmonary function abnormalities in Sj&ouml;gren's syndrome and the sicca complex. Thorax 1981; 36:286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/16\">",
"      Shi JH, Liu HR, Xu WB, et al. Pulmonary Manifestations of Sj&ouml;gren's Syndrome. Respiration 2009; 78:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/17\">",
"      Kurumagawa T, Kobayashi H, Motoyoshi K. Potential involvement of subclinical Sj&ouml;gren's syndrome in various lung diseases. Respirology 2005; 10:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/18\">",
"      Watanabe M, Naniwa T, Hara M, et al. Pulmonary manifestations in Sjogren's syndrome: correlation analysis between chest computed tomographic findings and clinical subsets with poor prognosis in 80 patients. J Rheumatol 2010; 37:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/19\">",
"      Kokosi M, Riemer EC, Highland KB. Pulmonary involvement in Sj&ouml;gren syndrome. Clin Chest Med 2010; 31:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/20\">",
"      Ito I, Nagai S, Kitaichi M, et al. Pulmonary manifestations of primary Sjogren's syndrome: a clinical, radiologic, and pathologic study. Am J Respir Crit Care Med 2005; 171:632.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/21\">",
"      Parambil JG, Myers JL, Lindell RM, et al. Interstitial lung disease in primary Sj&ouml;gren syndrome. Chest 2006; 130:1489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/22\">",
"      Deheinzelin D, Capelozzi VL, Kairalla RA, et al. Interstitial lung disease in primary Sj&ouml;gren's syndrome. Clinical-pathological evaluation and response to treatment. Am J Respir Crit Care Med 1996; 154:794.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/23\">",
"      Uffmann M, Kiener HP, Bankier AA, et al. Lung manifestation in asymptomatic patients with primary Sj&ouml;gren syndrome: assessment with high resolution CT and pulmonary function tests. J Thorac Imaging 2001; 16:282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/24\">",
"      Davidson BK, Kelly CA, Griffiths ID. Ten year follow up of pulmonary function in patients with primary Sj&ouml;gren's syndrome. Ann Rheum Dis 2000; 59:709.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/25\">",
"      Constantopoulos SH, Drosos AA, Maddison PJ, Moutsopoulos HM. Xerotrachea and interstitial lung disease in primary Sjogren's syndrome. Respiration 1984; 46:310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/26\">",
"      Ramagopalan SV, Wotton CJ, Handel AE, et al. Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study. BMC Med 2011; 9:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/27\">",
"      Launay D, Hachulla E, Hatron PY, et al. Pulmonary arterial hypertension: a rare complication of primary Sj&ouml;gren syndrome: report of 9 new cases and review of the literature. Medicine (Baltimore) 2007; 86:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/28\">",
"      Hatron PY, Wallaert B, Gosset D, et al. Subclinical lung inflammation in primary Sj&ouml;gren's syndrome. Relationship between bronchoalveolar lavage cellular analysis findings and characteristics of the disease. Arthritis Rheum 1987; 30:1226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/29\">",
"      Ramos-Casals M, Brito-Zer&oacute;n P, Garc&iacute;a-Carrasco M, Font J. Sarcoidosis or Sj&ouml;gren syndrome? Clues to defining mimicry or coexistence in 59 cases. Medicine (Baltimore) 2004; 83:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/30\">",
"      Travis WD, Galvin JR. Non-neoplastic pulmonary lymphoid lesions. Thorax 2001; 56:964.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/31\">",
"      Zen Y, Nakanuma Y. IgG4-related disease: a cross-sectional study of 114 cases. Am J Surg Pathol 2010; 34:1812.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/32\">",
"      Kobayashi H, Shimokawaji T, Kanoh S, et al. IgG4-positive pulmonary disease. J Thorac Imaging 2007; 22:360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/33\">",
"      Dalavanga YA, Constantopoulos SH, Galanopoulou V, et al. Alveolitis correlates with clinical pulmonary involvement in primary Sj&ouml;gren's syndrome. Chest 1991; 99:1394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/34\">",
"      Barranquero-Beltr&aacute;n A, Meyer O, Haim T, et al. [Comparative profile of antinuclear antibodies in Gougerot-Sj&ouml;gren syndrome with and without diffuse interstitial pulmonary fibrosis]. Rev Rhum Mal Osteoartic 1986; 53:615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/35\">",
"      Fischer A, Swigris JJ, du Bois RM, et al. Minor salivary gland biopsy to detect primary Sjogren syndrome in patients with interstitial lung disease. Chest 2009; 136:1072.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/36\">",
"      Matsuyama N, Ashizawa K, Okimoto T, et al. Pulmonary lesions associated with Sj&ouml;gren's syndrome: radiographic and CT findings. Br J Radiol 2003; 76:880.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/37\">",
"      Sakamoto O, Saita N, Ando M, et al. Two cases of Sj&ouml;gren's syndrome with multiple bullae. Intern Med 2002; 41:124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/38\">",
"      Gardiner P, Ward C, Allison A, et al. Pleuropulmonary abnormalities in primary Sj&ouml;gren's syndrome. J Rheumatol 1993; 20:831.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/39\">",
"      Franquet T, Gim&eacute;nez A, Monill JM, et al. Primary Sj&ouml;gren's syndrome and associated lung disease: CT findings in 50 patients. AJR Am J Roentgenol 1997; 169:655.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/40\">",
"      Koyama M, Johkoh T, Honda O, et al. Pulmonary involvement in primary Sj&ouml;gren's syndrome: spectrum of pulmonary abnormalities and computed tomography findings in 60 patients. J Thorac Imaging 2001; 16:290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/41\">",
"      Kim EA, Lee KS, Johkoh T, et al. Interstitial lung diseases associated with collagen vascular diseases: radiologic and histopathologic findings. Radiographics 2002; 22 Spec No:S151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/42\">",
"      Taouli B, Brauner MW, Mourey I, et al. Thin-section chest CT findings of primary Sj&ouml;gren's syndrome: correlation with pulmonary function. Eur Radiol 2002; 12:1504.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/43\">",
"      Salaffi F, Manganelli P, Carotti M, et al. A longitudinal study of pulmonary involvement in primary Sj&ouml;gren's syndrome: relationship between alveolitis and subsequent lung changes on high-resolution computed tomography. Br J Rheumatol 1998; 37:263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/44\">",
"      Papiris SA, Maniati M, Constantopoulos SH, et al. Lung involvement in primary Sj&ouml;gren's syndrome is mainly related to the small airway disease. Ann Rheum Dis 1999; 58:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/45\">",
"      Song MK, Seol YM, Park YE, et al. Pulmonary nodular lymphoid hyperplasia associated with Sj&ouml;gren's syndrome. Korean J Intern Med 2007; 22:192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/46\">",
"      Rajagopala S, Singh N, Gupta K, Gupta D. Pulmonary amyloidosis in Sjogren's syndrome: a case report and systematic review of the literature. Respirology 2010; 15:860.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/47\">",
"      Kelly C, Gardiner P, Pal B, Griffiths I. Lung function in primary Sj&ouml;gren's syndrome: a cross sectional and longitudinal study. Thorax 1991; 46:180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/48\">",
"      Brune, J, Emonot, A, Wiesendanger, T, et al. Syndrome de Gougerot-Sj&ouml;gren et fibrose pari&eacute;to-alv&eacute;olare diffuse. A propos de cinq observations. Rev Fr Mal Resp 1976; 4:560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/49\">",
"      Ziza JM, Kaplan G, Salomon C, Kahn MF. [Severe pulmonary fibrosis disclosing primary Gougerot-Sj&ouml;gren syndrome. Apropos of 5 cases, 2 of which were fatal]. Ann Med Interne (Paris) 1986; 137:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/50\">",
"      Dalavanga YA, Voulgari PV, Georgiadis AN, et al. Lymphocytic alveolitis: A surprising index of poor prognosis in patients with primary Sjogren's syndrome. Rheumatol Int 2006; 26:799.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/51\">",
"      Yamadori I, Fujita J, Bandoh S, et al. Nonspecific interstitial pneumonia as pulmonary involvement of primary Sj&ouml;gren's syndrome. Rheumatol Int 2002; 22:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/52\">",
"      Ioannou S, Toya SP, Tomos P, Tzelepis GE. Cryptogenic organizing pneumonia associated with primary Sjogren's syndrome. Rheumatol Int 2008; 28:1053.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/53\">",
"      Matteson EL, Ike RW. Bronchiolitis obliterans organizing pneumonia and Sj&ouml;gren's syndrome. J Rheumatol 1990; 17:676.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/54\">",
"      Tonami H, Matoba M, Yokota H, et al. CT and MR findings of bilateral lacrimal gland enlargement in Sj&ouml;gren syndrome. Clin Imaging 2002; 26:392.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/55\">",
"      Horiuchi Y, Hakugawa J, Shimizu K, et al. Massive cutaneous follicular lymphoid hyperplasia in a patient with the Sj&ouml;gren syndrome: 7-year follow-up and immunohistochemical study. Rheumatol Int 2006; 26:1044.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/56\">",
"      Ooms V, Decupere M, Lerut E, et al. Secondary renal amyloidosis due to long-standing tubulointerstitial nephritis in a patient with Sj&ouml;gren syndrome. Am J Kidney Dis 2005; 46:e75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/57\">",
"      Hansen LA, Prakash UB, Colby TV. Pulmonary lymphoma in Sj&ouml;gren's syndrome. Mayo Clin Proc 1989; 64:920.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/58\">",
"      Jeong YJ, Lee KS, Chung MP, et al. Amyloidosis and lymphoproliferative disease in Sj&ouml;gren syndrome: thin-section computed tomography findings and histopathologic comparisons. J Comput Assist Tomogr 2004; 28:776.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/59\">",
"      Perlat A, Decaux O, Gervais R, et al. Systemic light chain amyloidosis and Sjogren syndrome: an uncommon association. Amyloid 2009; 16:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/32/16906/abstract/60\">",
"      Nakamura N, Yamada G, Itoh T, et al. Pulmonary MALT lymphoma with amyloid production in a patient with primary Sj&ouml;gren's syndrome. Intern Med 2002; 41:309.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4301 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-197.136.42.3-BD8FD8CCCA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_32_16906=[""].join("\n");
var outline_f16_32_16906=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H20\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H346756766\">",
"      NOMENCLATURE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H87632609\">",
"      American-European criteria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H346756698\">",
"      Primary Sj&ouml;gren's syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H346756705\">",
"      Secondary Sj&ouml;gren's syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H327600\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H327647\">",
"      Xerotrachea",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H327669\">",
"      Pulmonary vascular disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H327676\">",
"      Sj&ouml;gren's syndrome and sarcoidosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H327683\">",
"      IgG4-related systemic disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9740885\">",
"      Other causes of diffuse parenchymal lung disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H346757511\">",
"      EVALUATION AND DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Laboratory",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Chest imaging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17659888\">",
"      - Chest radiograph",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17659895\">",
"      - High resolution computed tomography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Pulmonary function tests",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H346757694\">",
"      Minor salivary gland biopsy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Bronchoalveolar lavage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Lung biopsy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Histopathology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Nonspecific interstitial pneumonia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18332038\">",
"      - Lymphocytic interstitial pneumonia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14750069\">",
"      - Usual interstitial pneumonia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14749613\">",
"      - Organizing pneumonia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Follicular bronchiolitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Nodular lymphoid hyperplasia (pseudolymphoma)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3926787\">",
"      - Lymphoma",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H346757020\">",
"      - Pulmonary nodular amyloidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/4301\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/4301|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?0/30/481\" title=\"diagnostic image 1\">",
"      LIP CT scan",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/4301|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?27/22/28008\" title=\"picture 1\">",
"      Cellular NSIP histology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?43/22/44392\" title=\"picture 2\">",
"      Fibrosing NSIP histology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?12/20/12613\" title=\"picture 3\">",
"      LIP along vessels and bronchi",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?12/46/13032\" title=\"picture 4\">",
"      LIP with lymphoid hyperplasia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?6/20/6468\" title=\"picture 5\">",
"      LIP with germinal centers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?34/37/35415\" title=\"picture 6\">",
"      LIP with nodular inflammation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?35/1/35862\" title=\"picture 7A\">",
"      Nodular lymphoid hyperplasia Low",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?18/56/19332\" title=\"picture 7B\">",
"      Nodular lymphoid hyperplasia High I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?32/54/33637\" title=\"picture 7C\">",
"      Nodular lymphoid hyperplasia High II",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/4301|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?32/33/33308\" title=\"table 1\">",
"      Revised internat criteria SS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?37/39/38524\" title=\"table 2\">",
"      Differential dx Sjogrens synd",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?35/43/36539\" title=\"table 3\">",
"      Spectrum of IgG4 systemic disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?19/8/19596\" title=\"table 4\">",
"      Histologic features NSIP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?22/25/22939\" title=\"table 5\">",
"      Histologic features LIP",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/31/1530?source=related_link\">",
"      An overview of amyloidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/20/22856?source=related_link\">",
"      Approach to the adult with interstitial lung disease: Clinical evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/18/16681?source=related_link\">",
"      Approach to the adult with interstitial lung disease: Diagnostic testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/14/40168?source=related_link\">",
"      Autoimmune pancreatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/41/25239?source=related_link\">",
"      Basic principles and technique of bronchoalveolar lavage",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/43/24247?source=related_link\">",
"      Bronchiolitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/22/18794?source=related_link\">",
"      Classification and diagnosis of Sj&ouml;gren's syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/25/21914?source=related_link\">",
"      Clinical manifestations and diagnosis of sarcoidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/1/11287?source=related_link\">",
"      Clinical manifestations of Sj&ouml;gren's syndrome: Exocrine gland disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/42/27306?source=related_link\">",
"      Clinical manifestations of Sj&ouml;gren's syndrome: Extraglandular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/45/26329?source=related_link\">",
"      Clinical manifestations of systemic sclerosis (scleroderma) lung disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/9/19610?source=related_link\">",
"      Clinical manifestations, pathologic features, and diagnosis of extranodal (MALT) and nodal marginal zone lymphomas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/61/27610?source=related_link\">",
"      Clinical presentation and diagnosis of non-Hodgkin lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/15/7418?source=related_link\">",
"      Clinical presentation, laboratory manifestations, and diagnosis of immunoglobulin light chain (AL) amyloidosis (primary amyloidosis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/60/19402?source=related_link\">",
"      Cryptogenic organizing pneumonia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/57/6042?source=related_link\">",
"      Diagnosis of acute pulmonary embolism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/29/16858?source=related_link\">",
"      High resolution computed tomography of the lungs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/23/4474?source=related_link\">",
"      Idiopathic interstitial pneumonias: Clinical manifestations and pathology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/37/25174?source=related_link\">",
"      Interstitial lung disease associated with Sj&ouml;gren's syndrome: Management and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/7/24697?source=related_link\">",
"      Interstitial lung disease in dermatomyositis and polymyositis: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/31/17912?source=related_link\">",
"      Interstitial lung disease in rheumatoid arthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/25/409?source=related_link\">",
"      Lymphoid interstitial pneumonia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/25/42393?source=related_link\">",
"      Nonspecific interstitial pneumonia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/55/13178?source=related_link\">",
"      Overview of IgG4-related disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/21/26969?source=related_link\">",
"      Overview of lung disease associated with rheumatoid arthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/36/25162?source=related_link\">",
"      Pathogenesis of Sj&ouml;gren's syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/14/6376?source=related_link\">",
"      Pathogenesis of sarcoidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/60/11210?source=related_link\">",
"      Pulmonary manifestations of systemic lupus erythematosus in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/36/16968?source=related_link\">",
"      Role of bronchoalveolar lavage in diagnosis of interstitial lung disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/26/424?source=related_link\">",
"      Role of lung biopsy in the diagnosis of interstitial lung disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/23/8568?source=related_link\">",
"      The anti-Ro/SSA and anti-La/SSB antigen-antibody systems",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/24/35210?source=related_link\">",
"      Treatment of pulmonary hypertension in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_32_16907="Ectopic risk by contraceptive";
var content_f16_32_16907=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F75321&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F75321&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Ectopic pregnancies as a proportion of all pregnancies by contraceptive method",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Contraceptive method",
"       </td>",
"       <td class=\"subtitle1\">",
"        Ectopic pregnancy/All pregnancies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Levonorgestrel intrauterine device",
"       </td>",
"       <td>",
"        1:2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tubal sterilization",
"       </td>",
"       <td>",
"        1:3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Copper intrauterine device",
"       </td>",
"       <td>",
"        1:16",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Norethindrone-only pill",
"       </td>",
"       <td>",
"        1:20",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Norgestrel-only pill",
"       </td>",
"       <td>",
"        1:21",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Combination pills",
"       </td>",
"       <td>",
"        0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         All women",
"        </strong>",
"       </td>",
"       <td>",
"        1:50",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from United Stated Food and Drug Administration reviews of data submitted by drug manufacturers to support marketing approval. Furlong, LA. J Reprod Med 2002; 47:881.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_32_16907=[""].join("\n");
var outline_f16_32_16907=null;
var title_f16_32_16908="Resumption anticoag after ICH";
var content_f16_32_16908=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F79024&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F79024&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Timing of re-anticoagulation of patients with warfarin-associated intracerebral hemorrhage",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Study",
"       </td>",
"       <td class=\"subtitle1\">",
"        N",
"       </td>",
"       <td class=\"subtitle1\">",
"        Initiation of anticoagulation and outcomes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Punthakee, et al (2003)",
"       </td>",
"       <td>",
"        7",
"       </td>",
"       <td>",
"        Warfarin started a mean of 14 days (9-15 days in 4 pts); no ICH enlargement or thrombotic events.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Kawamata, et al (1995)",
"       </td>",
"       <td>",
"        13",
"       </td>",
"       <td>",
"        Six underwent surgery. Of 20 patients with intracranial hemorrhages and prosthetic valves, one thromboembolism in a setting of early postoperative heparin.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Butler and Tait (1998)",
"       </td>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        Heparin on day 3 (range 1-6) and warfarin on day 7 (range 3-19) in 10 patients with ICH (n=4) or subdural hematomas (n=6); no ICH enlargement or thrombotic events.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bertram, et al (2000)",
"       </td>",
"       <td>",
"        13",
"       </td>",
"       <td>",
"        Full-dose intravenous heparin on days 1 and 2 to seven patients, with hematoma enlargement in two. Of six patients given low-dose heparin, three had ischemic strokes on days 2, 4, and 5 (all had previously been treated with prothrombin complex concentrates).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Phan, et al (2000)",
"       </td>",
"       <td>",
"        87",
"       </td>",
"       <td>",
"        Anticoagulation withheld for mean of 10 days, acute treatment to reverse anticoagulation not reported, and one ischemic stroke. The 30-day thromboembolism rate estimated as 3 percent for those with prosthetic cardiac valves.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Babikian, et al (1998)",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        Of six patients with prosthetic cardiac valves (3 with ICHs and 3 with subdurals), warfarin interrupted for a mean of 19 days without thromboembolism.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Leker and Abramsky (1998)",
"       </td>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        Four patients given IV heparin 24-36 hours as soon as INR &lt;1.5 following vitamin K and plasma infusion. No worsening.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gomez, et al (1988)",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        Heparin on day 10 without hemorrhagic worsening in one patient.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     ICH: intracerebral hemorrhage.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_32_16908=[""].join("\n");
var outline_f16_32_16908=null;
var title_f16_32_16909="RDA for lactation";
var content_f16_32_16909=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F81797&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F81797&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Recommended daily allowances (RDA) for lactating women",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Nutrient (unit of measure per day)",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"3\" rowspan=\"1\">",
"        Age of lactating women",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        14 to 18 years old",
"       </td>",
"       <td class=\"subtitle2\">",
"        19 to 30 years old",
"       </td>",
"       <td class=\"subtitle2\">",
"        31 to 50 years old",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Energy (kcal)",
"       </td>",
"       <td>",
"        +500",
"       </td>",
"       <td>",
"        +500",
"       </td>",
"       <td>",
"        +500",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Protein (grams)",
"       </td>",
"       <td>",
"        71",
"       </td>",
"       <td>",
"        71",
"       </td>",
"       <td>",
"        71",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Vitamin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        A (ug)",
"       </td>",
"       <td>",
"        1200",
"       </td>",
"       <td>",
"        1300",
"       </td>",
"       <td>",
"        1300",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        C (ug)",
"       </td>",
"       <td>",
"        115",
"       </td>",
"       <td>",
"        120",
"       </td>",
"       <td>",
"        120",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        D (ug)",
"       </td>",
"       <td>",
"        5",
"       </td>",
"       <td>",
"        5",
"       </td>",
"       <td>",
"        5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        E (ug)",
"       </td>",
"       <td>",
"        19",
"       </td>",
"       <td>",
"        19",
"       </td>",
"       <td>",
"        19",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        K (ug)",
"       </td>",
"       <td>",
"        75",
"       </td>",
"       <td>",
"        90",
"       </td>",
"       <td>",
"        90",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        B6 (mg)",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        B12 (mg)",
"       </td>",
"       <td>",
"        2.8",
"       </td>",
"       <td>",
"        2.8",
"       </td>",
"       <td>",
"        2.8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Folate (ug)",
"       </td>",
"       <td>",
"        500",
"       </td>",
"       <td>",
"        500",
"       </td>",
"       <td>",
"        500",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Niacin (mg)",
"       </td>",
"       <td>",
"        17",
"       </td>",
"       <td>",
"        17",
"       </td>",
"       <td>",
"        17",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Riboflavin (mg)",
"       </td>",
"       <td>",
"        1.6",
"       </td>",
"       <td>",
"        1.6",
"       </td>",
"       <td>",
"        1.6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Thiamine (mg)",
"       </td>",
"       <td>",
"        1.4",
"       </td>",
"       <td>",
"        1.4",
"       </td>",
"       <td>",
"        1.4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Elements",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Calcium (mg)",
"       </td>",
"       <td>",
"        1300",
"       </td>",
"       <td>",
"        1000",
"       </td>",
"       <td>",
"        1000",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Fluoride (ug)",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Iodine (ug)",
"       </td>",
"       <td>",
"        290",
"       </td>",
"       <td>",
"        290",
"       </td>",
"       <td>",
"        290",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Iron (mg)",
"       </td>",
"       <td>",
"        10",
"       </td>",
"       <td>",
"        9",
"       </td>",
"       <td>",
"        9",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Magnesium (mg)",
"       </td>",
"       <td>",
"        360",
"       </td>",
"       <td>",
"        310",
"       </td>",
"       <td>",
"        320",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Phosphorus (mg)",
"       </td>",
"       <td>",
"        1250",
"       </td>",
"       <td>",
"        700",
"       </td>",
"       <td>",
"        700",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Selenium (ug)",
"       </td>",
"       <td>",
"        70",
"       </td>",
"       <td>",
"        70",
"       </td>",
"       <td>",
"        70",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Zinc (mg)",
"       </td>",
"       <td>",
"        13",
"       </td>",
"       <td>",
"        12",
"       </td>",
"       <td>",
"        12",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Institute of Medicine: Food and Nutrition Board. Dietary Reference Intakes Table. Available at: www.iom.edu/cms/3788/4574.aspx. (Accessed December 29, 2006.)",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_32_16909=[""].join("\n");
var outline_f16_32_16909=null;
var title_f16_32_16910="Do compression stockings prevent post-thrombotic syndrome";
var content_f16_32_16910=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F52292&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F52292&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Do compression stockings prevent post-thrombotic syndrome?",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"12\" width=\"8%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        First author, year",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Group",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"3\">",
"        Incidence of PTS (percent)",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Patients (n)",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Stocking pressure (mmHg)",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Stocking length and type",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Interval diagnosis to stocking",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Stocking duration (years)",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Follow-up (years)",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Scoring system",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Mild/ moderate",
"       </td>",
"       <td class=\"subtitle2\">",
"        Severe",
"       </td>",
"       <td class=\"subtitle2\">",
"        Overall",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Brandjes",
"        <sup>",
"         [1]",
"        </sup>",
"        , 1997",
"       </td>",
"       <td>",
"        Control",
"       </td>",
"       <td>",
"        47",
"       </td>",
"       <td>",
"        23",
"       </td>",
"       <td>",
"        70",
"       </td>",
"       <td>",
"        98",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &ge;5",
"       </td>",
"       <td rowspan=\"2\">",
"        Villalta-Prandoni scale*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stocking",
"       </td>",
"       <td>",
"        20",
"       </td>",
"       <td>",
"        11",
"       </td>",
"       <td>",
"        31",
"       </td>",
"       <td>",
"        96",
"       </td>",
"       <td>",
"        <p>",
"         40 at ankle",
"        </p>",
"        <p>",
"         36 at lower calf",
"        </p>",
"        <p>",
"         21 at upper calf",
"        </p>",
"       </td>",
"       <td>",
"        GCS below knee",
"       </td>",
"       <td>",
"        2-3 weeks",
"       </td>",
"       <td>",
"        &ge;2",
"       </td>",
"       <td>",
"        &ge;5",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        Ginsberg",
"        <sup>",
"         [2]",
"        </sup>",
"        , 2001",
"       </td>",
"       <td>",
"        Control",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        28",
"       </td>",
"       <td>",
"        40",
"       </td>",
"       <td>",
"        Stockings 1-2 sizes too large",
"       </td>",
"       <td>",
"        Below knee or thigh (1-2 sizes too large)",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        1.8-4.9",
"       </td>",
"       <td rowspan=\"2\">",
"        &bull;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stocking",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        26",
"       </td>",
"       <td>",
"        42",
"       </td>",
"       <td>",
"        <p>",
"         20-30 below knee, n = 24",
"        </p>",
"        <p>",
"         30-40 below knee, n = 14",
"        </p>",
"        <p>",
"         30-40 thigh, n = 4",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         ECS below knee, n = 38",
"        </p>",
"        <p>",
"         ECS thigh length, n = 4",
"        </p>",
"       </td>",
"       <td>",
"        1 year",
"       </td>",
"       <td>",
"        1.4-4.6",
"       </td>",
"       <td>",
"        1.4-4.6",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        Partsch",
"        <sup>",
"         [3]",
"        </sup>",
"        , 2004",
"       </td>",
"       <td>",
"        Control",
"       </td>",
"       <td>",
"        82",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td>",
"        82",
"       </td>",
"       <td>",
"        11",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        No stockings for 9 days",
"       </td>",
"       <td>",
"        Bed rest 9 days, no stockings in all, then stockings in 8/11 (73 percent) x 2 years",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td rowspan=\"2\">",
"        Villalta-Prandoni scale*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stocking",
"       </td>",
"       <td>",
"        54",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td>",
"        54",
"       </td>",
"       <td>",
"        26",
"       </td>",
"       <td>",
"        30-40",
"       </td>",
"       <td>",
"        Thigh length ECS (n = 13) or gauze-zinc oxide and calamine impregnanted bandage on lower leg and firm thigh adhesive bandage (n = 13)",
"       </td>",
"       <td>",
"        Immediate",
"       </td>",
"       <td>",
"        9 days stockings or Unna boot in all, then stockings in 13/26 (50 percent) x 2 years",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        Prandoni",
"        <sup>",
"         [4]",
"        </sup>",
"        , 2004",
"       </td>",
"       <td>",
"        Control",
"       </td>",
"       <td>",
"        38",
"       </td>",
"       <td>",
"        11",
"       </td>",
"       <td>",
"        49",
"       </td>",
"       <td>",
"        90",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        3-5",
"       </td>",
"       <td rowspan=\"2\">",
"        Villalta-Prandoni scale*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stocking",
"       </td>",
"       <td>",
"        22",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        26",
"       </td>",
"       <td>",
"        90",
"       </td>",
"       <td>",
"        30-40 at ankle",
"       </td>",
"       <td>",
"        GSC below knee",
"       </td>",
"       <td>",
"        5-10 days",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        3-5",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        Aschwanden",
"        <sup>",
"         [5]",
"        </sup>",
"        , 2008",
"       </td>",
"       <td>",
"        Control",
"       </td>",
"       <td>",
"        20",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td>",
"        20",
"       </td>",
"       <td>",
"        85",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        2.9",
"       </td>",
"       <td rowspan=\"2\">",
"        CEAP classification",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stocking",
"       </td>",
"       <td>",
"        13",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td>",
"        13",
"       </td>",
"       <td>",
"        84",
"       </td>",
"       <td>",
"        26.3-36.1 at ankle",
"       </td>",
"       <td>",
"        CS below knee",
"       </td>",
"       <td>",
"        6 months",
"       </td>",
"       <td>",
"        3.2",
"       </td>",
"       <td>",
"        3.2",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     GCS: graduate compression stockings; ECS: elastic compression stockings; CS: compression stockings.",
"     <br/>",
"     * Villalta-Prandoni scale",
"     <sup>",
"      [6]",
"     </sup>",
"     .",
"     <br/>",
"     <span class=\"bullet\">",
"      &bull;",
"     </span>",
"     Typical pain plus swelling (1 month duration) occurring 6 months after acute deep venous thrombosis",
"     <sup>",
"      [2]",
"     </sup>",
"     .",
"     <br/>",
"     &Delta; CEAP (Clinical-Etiology-Anatomic-Pathophysiologic) classification",
"     <sup>",
"      [7]",
"     </sup>",
"     .",
"    </div>",
"    <div class=\"reference\">",
"     Sources:",
"     <br/>",
"     <ol>",
"      <li>",
"       Brandjes DP, B&uuml;ller HR, Heijboer H, et al. Randomized trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet 1997; 349:759.",
"      </li>",
"      <li>",
"       Ginsberg JS, Hirsh J, Julian J, et al. Prevention and treatment of postphlebitic syndrome: results of a 3 part study. Arch Intern Med 2001; 161:2105.",
"      </li>",
"      <li>",
"       Partsch H, Kaulich M, Mayer W. Immediate mobilisation in acute vein thrombosis reduces post thrombotic syndrome. Int Angiol 2004; 23:206.",
"      </li>",
"      <li>",
"       Prandoni P, Lensing AW, Prins MH, et al. Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial. Ann Intern Med 2004; 141:249.",
"      </li>",
"      <li>",
"       Aschwanden M, Jeanneret C, Koller MT, et al. Effect of prolonged treatment with compression stockings to prevent post-thrombotic sequelae: a randomized controlled trial. J Vasc Surg 2008; 47:1015.",
"      </li>",
"      <li>",
"       Villalta S, Bagatella P, Piccioli A, et al. Assessment of validity and reproducibility of a clinical scale for the post-thrombotic syndrome. Haemostasis 1994; 24:158a.",
"      </li>",
"      <li>",
"       Porter JM, Moneta GL. Reporting standards in venous disease: an update. International Consensus Committee on Chronic Venous Disease. J Vasc Surg 1995; 21:635.",
"      </li>",
"     </ol>",
"     <br/>",
"     Reproduced from: Musani MH, Matta F, Yaekoub AY, et al. Venous compression for prevention of postthrombotic syndrome: A meta-analysis. Am J Med 2010; 123:735. Illustration used with the permission of Elsevier Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_32_16910=[""].join("\n");
var outline_f16_32_16910=null;
var title_f16_32_16911="USPSTF grade C recommendations";
var content_f16_32_16911=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F78892%7EPC%2F58200%7EPC%2F72269&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F78892%7EPC%2F58200%7EPC%2F72269&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Adult screening and prevention recommendations of USPSTF (September 2012) C recommendations (low priority)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"2\" width=\"50%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Service",
"       </td>",
"       <td class=\"subtitle1\">",
"        Population",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Cardiovascular disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Screening for abdominal aortic aneurysm",
"       </td>",
"       <td>",
"        Never-smoking men ages 65 to 75",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Intensive behavioral dietary counseling",
"       </td>",
"       <td>",
"        Adults without risk factors for CVD and/or low readiness for change",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td class=\"indent1\">",
"        Lipid disorders",
"       </td>",
"       <td>",
"        Men ages 20 to 35 and women with no risk factors",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Cancer",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Screening for breast cancer",
"       </td>",
"       <td>",
"        Women ages 40 to 49",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td class=\"indent1\">",
"        Screening for colorectal cancer",
"       </td>",
"       <td>",
"        Men and women ages 76 to 85 years",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Sexually transmitted infections",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td class=\"indent1\">",
"        Screening for chlamydia",
"       </td>",
"       <td>",
"        Low-risk women; low-risk pregnant women and age 26+",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Other conditions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Behavioral counseling to promote a healthy diet and physcial activity",
"       </td>",
"       <td>",
"        Clinicians may choose to selectively consel patients (based upon risk for CVD, readiness for change, and resources to support change)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Screening for osteoporosis",
"       </td>",
"       <td>",
"        Women younger than age 60; women 60 to 64 without risk factors",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    C: low priority, provide only for individual considerations.",
"    <div class=\"footnotes\">",
"     USPSTF: United States Preventive Services Task Force; CVD: cardiovascular disease.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Adult screening and prevention recommendations of USPSTF (August 2012) D recommendations (discourage testing)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"2\" width=\"50%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Service",
"       </td>",
"       <td class=\"subtitle1\">",
"        Population",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Cardiovascular disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Screening for abdominal aortic aneurysm",
"       </td>",
"       <td>",
"        Women",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Aspirin to prevent CVD",
"       </td>",
"       <td>",
"        Men under age 45",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Aspirin to prevent ischemic stroke",
"       </td>",
"       <td>",
"        Women under age 55",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Screening for asymptomatic carotid artery stenosis",
"       </td>",
"       <td>",
"        Adult men and women",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Screening for coronary heart disease (ECG, ETT, or EBCT)",
"       </td>",
"       <td>",
"        Adults not at increased risk",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td class=\"indent1\">",
"        Screening for peripheral arterial disease",
"       </td>",
"       <td>",
"        Adults",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Cancer",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Chemoprevention of breast cancer",
"       </td>",
"       <td>",
"        Women not at increased risk of breast cancer",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Screening for breast cancer by teaching BSE",
"       </td>",
"       <td>",
"        All women",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        BRCA mutation testing for breast and ovarian cancer",
"       </td>",
"       <td>",
"        Women whose family history is not associated with an increased risk for deleterious mutations in BRCA 2 or BRCA 2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Screening for bladder cancer",
"       </td>",
"       <td>",
"        Adults",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Cervical cancer screening with Pap smear",
"       </td>",
"       <td>",
"        Women over age 65 who have had previous negative screens; women who have had total hysterectomy for benign disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Screening for colorectal cancer",
"       </td>",
"       <td>",
"        Men and women ages 86 years and older",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Aspirin and NSAIDs to prevent colorectal cancer",
"       </td>",
"       <td>",
"        Men under age 45; women under age 55",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Screening for ovarian cancer",
"       </td>",
"       <td>",
"        Women",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Screening for pancreatic cancer",
"       </td>",
"       <td>",
"        Adults",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Screening for prostate cancer",
"       </td>",
"       <td>",
"        All men",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td class=\"indent1\">",
"        Screening for testicular cancer",
"       </td>",
"       <td>",
"        Men",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Sexually transmitted infections",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Screening for bacterial vaginosis",
"       </td>",
"       <td>",
"        Average risk",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Serologic screening for genital herpes simplex",
"       </td>",
"       <td>",
"        Asymptomatic pregnant women; asymptomatic adolescents and adults",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td class=\"indent1\">",
"        Screening for syphilis",
"       </td>",
"       <td>",
"        Not at increased risk",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Other conditions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Screening for asymptomatic bacteriuria",
"       </td>",
"       <td>",
"        Men and non-pregnant women",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Beta carotene supplements",
"       </td>",
"       <td>",
"        Adults",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Screening for chronic obstructive pulmonary disease with spirometry",
"       </td>",
"       <td>",
"        Adult men and women",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Screening for hepatitis B infection",
"       </td>",
"       <td>",
"        General population",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Screening for hepatitis C infection",
"       </td>",
"       <td>",
"        Not at increased risk",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Postmenopausal hormone therapy for primary prevention of chronic problems",
"       </td>",
"       <td>",
"        Postmenopausal women with or without a hysterectomy: estrogen plus progestin or estrogen alone",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Screening for idiopathic scoliosis",
"       </td>",
"       <td>",
"        Adolescents",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     D: discourage, unless unusual additional considerations; ECT: electrocardiogram; ETT: exercise tolerance test; EBCT: electron beam CT for coronary calcification; BSE: breast self-examination; USPSTF: United States Preventive Services Task Force.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Adult screening and prevention statements of USPSTF (September 2012) I statements (balance of benefits and harms uncertain)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"2\" width=\"50%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Service",
"       </td>",
"       <td class=\"subtitle1\">",
"        Population",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Cardiovascular disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Aspirin for CVD prevention",
"       </td>",
"       <td>",
"        Men and women &gt;age 80",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Screening for coronary heart disease by ECG, ETT, or EBCT",
"       </td>",
"       <td>",
"        Adults at increased risk of CHD events",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td class=\"indent1\">",
"        Screening for coronary heart disease risk by non-traditional risk factors*",
"       </td>",
"       <td>",
"        Adults men and women",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Cancer",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Breast cancer screening by CBE",
"       </td>",
"       <td>",
"        Women ages 50 to 75",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Breast cancer screening with digital mammography or MRI",
"       </td>",
"       <td>",
"        Adults",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Screening for colorectal cancer with computed tomographic colonography and fecal DNA testing",
"       </td>",
"       <td>",
"        Adults",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Screening for lung cancer",
"       </td>",
"       <td>",
"        Smokers with low-dose CT or CXR or sputum cytology",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Screening for oral cancer",
"       </td>",
"       <td>",
"        Adults",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Counseling to prevent skin cancer",
"       </td>",
"       <td>",
"        Age &gt;24 years",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td class=\"indent1\">",
"        Screening for skin cancer with total body exam",
"       </td>",
"       <td>",
"        All",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Diabetes mellitus",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td class=\"indent1\">",
"        Screening for type 2 diabetes",
"       </td>",
"       <td>",
"        Adults with BP &lt;135/80",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Injury prevention",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Interventions to prevent low back pain",
"       </td>",
"       <td>",
"        Adults",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td class=\"indent1\">",
"        Routine behavioral counseling about proper use of motor vehicle occupant restraints and avoidance of alcohol while driving",
"       </td>",
"       <td>",
"        Men and women",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Lifestyle-related problems",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td class=\"indent1\">",
"        Screening for tobacco use and provide tobacco cessation interventions",
"       </td>",
"       <td>",
"        Adolescents and children",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Sexually transmitted infections",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Routine behavioral counseling to prevent sexually transmitted infections",
"       </td>",
"       <td>",
"        Adolescents and adults not at increased risk",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Screening for bacterial vaginosis",
"       </td>",
"       <td>",
"        Increased-risk women",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td class=\"indent1\">",
"        Screening for chlamydia",
"       </td>",
"       <td>",
"        Men",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Substance abuse",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Screening for alcohol misuse",
"       </td>",
"       <td>",
"        Adolescents",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td class=\"indent1\">",
"        Screening for illicit drug use",
"       </td>",
"       <td>",
"        Adolescents and adults",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Vision and hearing problems",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Screening for glaucoma",
"       </td>",
"       <td>",
"        Adults",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Screening for hearing loss",
"       </td>",
"       <td>",
"        Adults",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td class=\"indent1\">",
"        Screening for impaired visual acuity",
"       </td>",
"       <td>",
"        Adults",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Other conditions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Brief interventions or peer counseling to promote breast feeding",
"       </td>",
"       <td>",
"        Women after child birth",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Screening for chronic kidney disease",
"       </td>",
"       <td>",
"        Older adults (&ge;50 years)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Screening for dementia",
"       </td>",
"       <td>",
"        Older adults",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Screening for family and intimate partner violence",
"       </td>",
"       <td>",
"        Parents or guardians, women, older adults",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Screening for hepatitis C infection",
"       </td>",
"       <td>",
"        Increased risk",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Screening for osteoporosis in men",
"       </td>",
"       <td>",
"        Adults",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Screening for suicide risk",
"       </td>",
"       <td>",
"        Adults",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Screening for thyroid disease",
"       </td>",
"       <td>",
"        Adults",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Supplemental vitamins, A, C, and E or folic acid or antioxidant combinations",
"       </td>",
"       <td>",
"        Adults",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    I: uncertain benefit.",
"    <div class=\"footnotes\">",
"     ECT: electrocardiogram; ETT: exercise tolerance test; EBCT: electron beam CT for coronary calcification; USPSTF: United States Preventive Services Task Force; CT: computed tomography; CXR: chest x-ray; CBE: clinical breast examination.",
"     <br>",
"      * hs-CRP, ankle-brachial index, carotid artery intima-media thickness, EBCT, homocysteine, lipoprotein (a).",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_32_16911=[""].join("\n");
var outline_f16_32_16911=null;
